Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Icg Enterprise Trust Plc Gbp
Preliminary Results for the twelve months ended 31 January 2026
Published May 7 2026
59 min read

Preliminary Results for the twelve months ended 31 January 2026

news images

 

ICG Enterprise Trust plc
Preliminary Results for the twelve months ended 31 January 2026
7 May 2026

 

 

 

 

 

Highlights

  • Portfolio Return on a Local Currency Basis of 4.8% (5-year annualised: 11.8%)

  • Negative FX impact of (3.6)% due to one of the largest 12-month appreciations of GBP vs USD in a decade. Over last 5 and 10 years, FX impact broadly neutral

  • NAV per Share Total Return of 0.5% and Share Price Total Return of 17.3%. NAV per Share of 2,045p at 31 Jan 2026

  • Portfolio net cashflow of £188m, with 25% of Opening Portfolio Value realised during the year

  • 49 Full Exits during the year at a weighted-average Multiple of Cost of 3.0x and Uplift to Carrying Value of 11.2%

  • Robust balance sheet: £227m total available liquidity; £33m net debt (£1,353m Portfolio Value)

  • Buybacks of £28m during year added 22p to NAV per Share. Total dividends of 39p per share for FY26 (+8% YoY; 13th consecutive year of ordinary dividend per share increases). Board renews both buyback programmes and reaffirms progressive dividend policy

 

 

 

 


 

Jane Tufnell

 

Oliver Gardey

 

 

 

Chair of ICG Enterprise Trust plc

 

Portfolio Manager for ICG Enterprise Trust plc

 

 

 

 

"ICGT's Portfolio of mature, profitable private companies has remained resilient during FY26.

In recent years the Board and Manager have taken a number of steps to enhance ICGT's offering to shareholders, including through a differentiated capital allocation policy. This year, we have returned £51m to shareholders through buybacks and dividends, equivalent to 4% of opening NAV. The Board is renewing the long-term and opportunistic buyback programmes for FY27, and is reaffirming its commitment to the progressive dividend policy. Over the last five years, dividends per share have grown at an annualised rate of 10%.

As an investment trust, ICGT does not need to accommodate subscriptions or redemptions. This enables us to manage the Portfolio actively to achieve long-term compounding growth for our shareholders. With our low net debt and high liquidity, we are well positioned to continue executing our strategy into FY27 and beyond."

 

 

"Our actively-managed Portfolio is performing well across a number of important metrics. EBITDA growth of our portfolio companies was approximately 13% over the last twelve months1, and 25% of the opening Portfolio value was realised during the year.

ICGT's low net debt and high liquidity gives us the flexibility to continue to deploy capital into high quality new investments, maintaining vintage diversification to support long-term growth.

Macroeconomic uncertainty has risen post year-end; transaction activity in the near-term may slow. However, the Portfolio is positioned to benefit from a number of growth trends, with broad diversification and low leverage. This provides resilience and flexibility in the face of market turbulence."

 

 

1 Based on Enlarged Perimeter covering 70% of the Portfolio

PERFORMANCE OVERVIEW

 

 

 

 

Annualised

Performance to 31 January 2026

3 months

6 months

1 year

3 years

5 years

10 years

Portfolio Return on a Local Currency Basis

1.5%

2.9%

4.8%

7.0%

11.8%

14.9%

NAV per Share Total Return

(1.1)%

1.2%

0.5%

4.2%

10.0%

12.9%

Share Price Total Return

0.5%

4.4%

17.3%

13.1%

12.6%

13.8%

FTSE All-Share Index Total Return

5.7%

12.7%

21.1%

13.0%

12.6%

9.0%


Financial year ended:

Jan 2022

Jan 2023

Jan 2024

Jan 2025

Jan 2026

Fund performance





Portfolio return (local currency)

29.4%

10.5%

5.9%

10.2%

4.8%

Portfolio return (sterling)

27.6%

17.0%

3.2%

10.6%

1.2%

NAV

£1,158m

£1,301m

£1,283m

£1,332m

£1,273m

NAV per Share Total Return (%)

24.4%

14.5%

2.1%

10.5%

0.5%

 

 

 

 

 

 

 

Investment activity





New Investments

£304m

£287m

£137m

£181m

£194m

As % opening Portfolio

32%

24%

10%

13%

13%

Total Proceeds

£343m

£252m

£239m

£151m

£382m

As % opening Portfolio

36%

22%

17%

11%

25%

 

 

 

 

 

 

 

Shareholder experience







Closing share price

1,200p

1,150p

1,226p

1,342p

1,534p

Total dividends per share

27p

30p

33p

36p

39p

Share Price Total Return

27.1%

(2.3)%

9.6%

12.5%

17.3%

Total shareholder distributions

£21m

£22m

£35m

£59m

£51m

As % Opening NAV

2.2%

1.9%

2.7%

4.5%

3.9%


Portfolio activity overview for FY26

Primary

Direct

Secondary

Total

ICG-managed

Local Currency return

5.2%

6.0%

0.8%

4.8%

6.9%

Sterling return

2.5%

1.5%

(4.3)%

1.2%

3.4%

New Investments

£84m

£69m

£41m

£194m

£62m

Total Proceeds

£192m

£126m

£64m

£382m

£113m

New Fund Commitments

£134m

£67m

£201m

£108m

Closing Portfolio value

£701m

£457m

£195m

£1,353m

£398m

% Total Portfolio

51.8%

33.8%

14.4%

100.0%

29.4%

COMPANY TIMETABLE
A presentation for investors and analysts will be held at 10:30am BST today. A link to the presentation can be found on the Results & Reports page of the Company website. A recording of the presentation will be made available on the Company website after the event.

 

 

FY26 Final Dividend

Ex-dividend date

 

2 July 2026

Record date

 

3 July 2026

Dividend payment date

 

17 July 2026


Annual General Meeting
The Annual General Meeting will be held on Thursday 25 June 2026. The Board will be communicating the format of the meeting separately in the Notice of Meeting. This will include details of how shareholders may register their interest in attending the Annual General Meeting.

Shareholder Seminar
In March 2026, ICGT held its annual Shareholder Seminar. We explored a number of topics:

  • 2025 in review – including several realisation case studies

  • Our new and established manager relationships – across both ICG plc and leading third party managers

  • Inside ICG Europe Mid-Market – insights from the ICG Europe team on current themes and deal flow

  • Positioning for long term growth – why ICGT’s portfolio can benefit from several long-term growth trends



A recording is available at this link:
https://www.icg-enterprise.co.uk/cmd

ENQUIRIES

Institutional investors and analysts:

Martin Li, Shareholder Relations                        +44 (0) 20 3545 1816
Nathan Brown, Deutsche Numis                        +44 (0) 20 7260 1426
David Harris, Cadarn Capital                             +44 (0) 20 7019 9042

Media:

Clare Glynn, Corporate Communications, ICG  +44 (0) 20 3545 1850

ABOUT ICG ENTERPRISE TRUST

ICG Enterprise Trust is a leading listed private equity investor focused on creating long-term growth by delivering consistently strong returns through selectively investing in profitable, cash-generative private companies, primarily in Europe and the US, while offering the added benefit to shareholders of daily liquidity.

We invest in companies directly as well as through funds managed by ICG plc and other leading private equity managers who focus on creating long-term value and building sustainable growth through active management and strategic change.

NOTES

Included in this document are Alternative Performance Measures (“APMs”). APMs have been used if considered by the Board and the Manager to be the most relevant basis for shareholders in assessing the overall performance of the Company, and for comparing the performance of the Company to its peers and its previously reported results. The Glossary includes further details of APMs and reconciliations to International Financial Reporting Standards (“IFRS”) measures, where appropriate.

In the Manager’s Review and Supplementary Information, all performance figures are stated on a Total Return basis (i.e. including the effect of re-invested dividends). ICG Alternative Investment Limited, a regulated subsidiary of Intermediate Capital Group plc, acts as the Manager of the Company.

DISCLAIMER

The information contained herein and on the pages that follow does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, any securities in any jurisdiction where such an offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on ICG Enterprise Trust PLC (the "Company") or its affiliates or agents. Equity securities in the Company have not been and will not be registered under the applicable securities laws of the United States, Australia, Canada, Japan or South Africa (each an “Excluded Jurisdiction”). The equity securities in the Company referred to herein and on the pages that follow may not be offered or sold within an Excluded Jurisdiction, or to any U.S. person ("U.S. Person") as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or to any national, resident or citizen of an Excluded Jurisdiction.

The information on the pages that follow may contain forward looking statements. Any statement other than a statement of historical fact is a forward looking statement. Actual results may differ materially from those expressed or implied by any forward looking statement. The Company does not undertake any obligation to update or revise any forward looking statements. You should not place undue reliance on any forward looking statement, which speaks only as of the date of its issuance.

CHAIR’S STATEMENT

Dear fellow shareholders,

ICGT’s strategy is to invest in profitable, cash-generative private companies that can deliver long-term growth. A share in the Company provides access to a unique portfolio of such companies in the US and Europe, which is impossible to replicate in public markets.

For the 12 months to 31 January 2026, ICGT generated a NAV per Share Total Return of 0.5% and the discount to NAV of its shares narrowed from 35% to 24%. Shareholders received a Share Price Total Return of 17.3% for the year.

Over the last five years, ICGT has delivered an annualised NAV per Share Total Return of 10.0% and an annualised Share Price Total Return of 12.6%.

In the months between the end of our financial year and the publication of this report, the environment for private equity has become more complicated and macroeconomic uncertainty has increased in a number of areas. In that context, I am confident in the experienced and dedicated team that manages ICGT, and I believe the Company has an attractive portfolio. We will remain focused on executing our investment strategy and allocating our capital thoughtfully.

Performance

ICGT’s portfolio returned 4.8% in local currency terms and 1.2% in sterling terms during FY26. Portfolio companies in aggregate have continued to generate double digit growth in profits1, and have modest leverage in the context of private equity.

NAV per Share Total Return was 0.5% for FY26. This was a disappointing result albeit in a challenging market. The Board continues to have great confidence in our Portfolio of mature cash generative companies to deliver attractive returns for our shareholders.

At 31 January 2026, ICGT had net debt of £33m and Total Available Liquidity of £227m, which the Board judges appropriate in the current environment.

Shareholder engagement

2025 saw a high level of engagement with shareholders. I and the Manager met with a wide range of investors, and we welcomed several new investors to our shareholder register. We were also pleased to win Investment Week’s ‘Investment Company of the Year 2025’ award in the private equity category.

These conversations, together with the newsletter survey the Manager ran in October 2025, have helped to refine our programme of initiatives to engage with our existing shareholder base and attract new investors. The Board will oversee delivery of these initiatives and monitor their effectiveness.

Capital allocation

During the year, the Manager made new investments of £194m and committed £201m to new funds, in line with the programme approved and regularly reviewed by the Board. The Portfolio generated net cashflow of £188m.

Alongside this investment activity, ICGT bought back 3% of its opening share count at an average discount of 32.3%. The Board regularly reviews the effectiveness of the programmes with the Manager and our advisers. The share buybacks undertaken during the year enhanced the NAV per Share Total Return by 1.1%.

We maintain the progressive dividend policy, with total FY26 dividends of 39p per share. This represents an 8% increase on the prior year and the 13th consecutive year of ordinary dividend per share increases.

Looking ahead

I believe there is substantial value in ICGT’s shares, and your Board is committed to working with the Manager and other partners to support the marketing of ICGT to a wide range of current and potential shareholders.

ICGT is managed by an experienced team with the resources, network and track record to navigate complex markets. The Company has a robust capital structure and liquidity, and an investment strategy that supports our objective of delivering long-term compounding returns.

Thank you for your continued support.

Jane Tufnell
Chair
6 May 2026

1 EBITDA, based on Enlarged Perimeter covering 70% of the Portfolio.

MANAGER’S REVIEW

Alternative Performance Measures

The Board and the Manager monitor the financial performance of the Company on the basis of Alternative Performance Measures (‘APM’), which are non-UK-adopted IAS measures. The APM predominantly form the basis of the financial measures discussed in this review, which the Board believes assists shareholders in assessing their investment and the delivery of the investment strategy.

The Company holds certain investments in subsidiary entities. The substantive difference between APM and UK-IAS is the treatment of the assets and liabilities of these subsidiaries. The APM basis ‘looks through’ these subsidiaries to the underlying assets and liabilities they hold, and it reports the investments as the Portfolio APM, gross of the liability in respect of the Co-investment Incentive Scheme. Under UK-IAS, the Company and its subsidiaries are reported separately. The assets and liabilities of the subsidiaries, which include the liability in respect of the Co-investment Incentive Scheme, are presented on the face of the UK-IAS balance sheet as a single carrying value. The same is true for the UK-IAS and APM basis of the cash flow statement.

The following table sets out UK-IAS metrics and the APM equivalents:

IFRS (£m)

31 January 2026

31 January 2025

APM (£m)

31 January 2026

31 January 2025

Investments

1,309

1,470

Portfolio

1,353

1,523

NAV

1,273

1,332

Realisation Proceeds

316

151

Cash flows from the sale of portfolio investments

60

20

Total Proceeds

382

151

Cash flows related to the purchase of portfolio investments

51

34

Total New Investment

194

181

 

 

 

 

 

 

The Glossary includes definitions for all APM and, where appropriate, a reconciliation between APM and UK-IAS.

Why private equity

Every day the lives of those living and working in the US and Western Europe are touched by companies owned by private equity: retailers, payments processors, home security, pet food, health services – the list is long. What typically unites these companies is that they are profitable and cash generative. These companies are actively managed by their shareholders, with management teams heavily incentivised to generate returns. Increasingly, companies with these characteristics are choosing to grow under private equity ownership and to stay private for longer. Within that, ICGT focuses on a subset of those companies that we expect will generate resilient growth. As more companies are owned by private equity, we believe it is a structurally attractive allocation within an investment portfolio, with a track record of attractive returns, and significant opportunity to continue that trajectory.

A share in ICGT gives you access to a unique portfolio of private companies.

Our investment strategy

Within developed markets, we focus on investing in buyouts of profitable, cash-generative businesses that exhibit resilient growth characteristics, which we believe will generate strong long-term compounding returns across economic cycles.

We take an active approach to Portfolio construction, with a flexible mandate that enables us to deploy capital in Primary, Secondary and Direct Investments. Geographically, we focus on the developed markets of North America and Europe which have deep and mature private equity markets.

 

Medium-term target

Five-year average1

31 January 2026

1. Target Portfolio composition 2

 

 

 

Investment category

 

 

 

Primary

~40-50%

53%

52%

Direct

~30-35%

30%

34%

Secondary

~25-30%

17%

14%

Geography

 

 

 

North America

~50%

45%

48%

Europe

~50%

49%

47%

Other

6%

5%

  1. Five-year average is the linear average of FY exposures for FY22-FY26.

  2. As a percentage of Portfolio.

ICG Enterprise Trust benefits from access to ICG-managed funds and Direct Investments, which represented 29% of the Portfolio value at period end and generated a 6.9% return on a Local Currency Basis.

Performance overview

At 31 January 2026, our Portfolio was valued at £1,353m, and the Portfolio Return on a Local Currency Basis for the financial year was 4.8% (FY25: 10.2%).

Due to the geographic diversification of our Portfolio, the reported value is impacted by changes in foreign exchange rates. During the period, FX movements affected the Portfolio negatively by £55m, driven by Sterling’s 10.4% appreciation against the US Dollar in the year. In sterling terms, Portfolio growth during the period was 1.2%.

The net result for shareholders was that ICG Enterprise Trust generated a NAV per Share Total Return of 0.5% during FY26, ending the period with a NAV per Share of 2,045p.

Movement in the Portfolio
£m

Twelve months to 31 January 2026

Twelve months to 31 January 2025

Opening Portfolio1

1,523

1,349

Total New Investments

194

181

Total Proceeds

(382)

(151)

Portfolio net cashflow

(188)

30

Valuation movement2

73

138

Currency movement

(55)

6

Closing Portfolio

1,353

1,523

1 Refer to the Glossary.
2 93% of the Portfolio valuations are dated 31 December 2025 or later (FY25: 97%).

 

 

NAV per Share Total Return

Twelve months to 31 January 2026

Twelve months to 31 January 2025

% Portfolio growth (local currency)

4.8%

10.2%

% currency movement

(3.6)%

0.4%

% Portfolio growth (Sterling)

1.2%

10.6%

Impact of gearing

0.2%

0.7%

Management fee

(1.2)%

(1.3)%

Finance costs and other expenses

(0.5)%

(0.6)%

Co-investment Incentive Scheme Accrual

(0.1)%

(0.7)%

Impact of share buybacks

1.1%

1.8%

NAV per Share Total Return

0.5%

10.5%

For Q4 the Portfolio Return on a Local Currency Basis was 1.5% and the NAV per Share Total Return was (1.1)%.

Executing our investment strategy

Commitments
in the financial year

Total New Investments
in the financial year

Growth
in the financial year

Total Proceeds
in the financial year

Making commitments to funds, which expect to be drawn over 3 to 5 years

Cash deployments into portfolio companies, either through funds or directly

Driving growth and value creation of our portfolio companies

Cash realisations of investments in Portfolio companies, plus Fund Disposals

£201m
(FY25: £83m)

£194m
(FY25: £181m)

£73m
(FY25: £138m)

£382m
(FY25: £151m)

Commitments

Our structure and investment mandate enable us to commit through the cycle, maintaining vintage diversification for our Portfolio and sowing the seeds for future growth.

During the year we made 11 new Fund Commitments totalling £201m, including £88m to funds managed by ICG plc, as detailed below:

 

 

Commitment during the period

Fund

Manager

Local currency

£m

ICG LP Secondaries Fund II

ICG

$90.0m

£67.3m

ICG Europe IX

ICG

€25.0m

£20.9m

Advent GPE XI

Advent

€20.0m

£17.1m

TH Lee X

THL

$20.0m

£15.8m

Hg Saturn IV

Hg

$20.0m

£15.4m

Green Equity Investor X

Leonard Green

$20.0m

£14.8m

Integrum II

Integrum

$18.0m

£13.8m

GHO Capital IV

GHO

€15.0m

£12.4m

New Mountain Strategic Equity II

New Mountain

$15.0m

£11.0m

Hg Genesis XI

Hg

€10.0m

£8.7m

Stone Point - Trident X

Stone Point

$5.0m

£3.7m

At 31 January 2026, ICG Enterprise Trust had outstanding Undrawn Commitments of £635.3m. Total Undrawn Commitments at 31 January 2026 comprised £470.5m of Undrawn Commitments to funds within their Investment Period, and a further £164.8m were to funds outside their Investment Period.

Movement in outstanding Commitments

Year to 31 January 2026 £m

Undrawn Commitments as at 1 February 2025

553.2

New Fund Commitments

201.0

New Commitments relating to Co-investments

79.5

Drawdowns

(193.7)

Currency and other movements, including repayment of commitments which can be reinvested

(4.7)

Undrawn commitments as at 31 January 2026

635.3


 

31 January 2026
£m

31 January 2025
£m

Undrawn Commitments – funds in Investment Period

470.5

419.1

Undrawn Commitments – funds outside Investment Period

164.8

134.1

Total Undrawn Commitments

635.3

553.2

Total available liquidity (including facility)

(227.1)

(124.6)

Overcommitment net of total available liquidity

408.2

428.6

Overcommitment % of net asset value

32.1%

31.1%

Commitments are made in the funds’ underlying currencies. The currency split of the Undrawn Commitments at 31 January 2026 was as follows:

 

31 January 2026

31 January 2025

Undrawn Commitments

£m

%

£m

%

US Dollar

381.6

60.1%

310.3

56.1%

Euro

229.1

36.1%

213.1

38.5%

Sterling

24.6

3.9%

29.8

5.4%

Total

635.3

100%

553.2

100%

Investments

Total New Investments were £194m during the period, of which 32% (£62m) were alongside ICG. New investments by category are detailed in the table below:

Investment Category



Cost (£m)

% of New Investments

Primary

84.3

43.4%

Direct

69.2

35.6%

Secondary

40.7

21.0%

Total

194.2

100.0%

The five largest new investments in the period were as follows:

Investment

Description

Manager

Country

Cost £m1

Project Domino

Diversified secondaries portfolio

ICG

Multiple

18.7

Dayforce

Provider of human capital management solutions

Thoma Bravo

United States

11.2

Global Market Foods

Specialty distributor of international foods

Audax

United States

10.9

Headlands Research

Operator of a network of clinical trial sites

TH Lee

United States

9.1

Minimax

Supplier of fire protection systems and services

ICG

Germany

8.3

Total of top 5 largest underlying new investments

58.1

1 Represents ICG Enterprise Trust’s indirect investment (share of fund cost) plus any Direct Investments in the period.

Occasionally ICGT simultaneously has both a realisation from and an investment into the same company in the same period. This typically occurs when an underlying fund sells a company that is purchased by another fund within ICGT’s portfolio. During FY26 shareholders will note that Minimax appears both in the top 5 realisations and top 5 new investments, which is a result of this situation.

Growth

The Portfolio grew by £73m (+4.8%) on a Local Currency Basis in the 12 months to 31 January 2026, driven by realised gains and supported by earnings growth on a weighted-average basis across the Enlarged Perimeter of 13%.

No single movement at the level of an individual fund or direct investment had a positive or negative impact of greater than 0.5% on the overall Portfolio valuation.

Growth across the Portfolio was split as follows:

  • By investment type: growth was spread across Primary (+5.2%), Secondary (+0.8%) and Direct (+6.0%)

  • By geography: North America and Europe experienced growth of +5.6% and +3.9% respectively

The growth in the Portfolio is underpinned by the performance of our portfolio companies, which delivered robust financial performance during the period:

 

Top 30

Enlarged Perimeter

Portfolio coverage

37%

70%

Last Twelve Months ('LTM') revenue growth

10%

10%

LTM EBITDA growth

14%

13%

Net Debt / EBITDA

4.7x

4.8x

Enterprise Value / EBITDA

15.9x

15.7x

Note: values are weighted averages for the respective Portfolio segment; Enlarged Perimeter represents the aggregate value of the Top 30 Companies and a representative sample of primary funds; see Glossary for definition and calculation methodology

Quoted Company Exposure

We do not actively invest in publicly quoted companies but gain listed investment exposure when IPOs are used as a route to exit an investment. In these cases, exit timing typically lies with the manager with whom we have invested.

At 31 January 2026, ICG Enterprise Trust’s exposure to quoted companies was valued at £52.4m, equivalent to 3.9% of the Portfolio value (31 January 2025: 4.8%). Across the Portfolio, quoted positions resulted in a £20.7m decrease in Portfolio NAV during the period. This negatively impacted the Portfolio Return on a Local Currency Basis by approximately 1.4%. The share price of our largest listed exposure, Chewy, decreased by 25% in local currency (USD) during the period.

At 31 January 2026, Chewy was the only quoted investment that individually accounted for 0.5% or more of the Portfolio value:

Company

Ticker

31 January 2026
% of Portfolio value

Chewy

CHWY-US

1.2%

Other companies

 

2.7%

Total

 

3.9%

Realisations

During FY26, the ICG Enterprise Trust Portfolio generated Total Proceeds of £382m.

Realisation activity during the period included 49 Full Exits generating proceeds of £196m. These were completed at a weighted average Uplift to Carrying Value of 11.2% and represent a weighted average Multiple to Cost of 3.0x for those investments.

The five largest underlying realisations in the period were as follows:

Investment

Description

Manager

Country

Proceeds £m

Minimax

Supplier of fire protection systems and services

ICG

Germany

48.8

Froneri

Manufacturer and distributor of ice cream products

PAI

United Kingdom

38.1

Datasite Global Corporation

Provider of SaaS software focused on virtual data rooms

ICG

United States

22.5

PSB Academy

Provider of private tertiary education

ICG

Singapore

19.2

European Camping Group

Operator of premium campsites and holiday parks

PAI

France

18.8

Total of 5 largest underlying realisations

 

147.4

Balance sheet and liquidity

Net assets at 31 January 2026 were £1,273m, equal to 2,045p per share.

The Company had net debt of £33m and at 31 January 2026, the Portfolio represented 106% of net assets (31 January 2025: 114%).

 

£m

% of net assets

Portfolio

1,352.9

106.3%

Cash

33.8

2.7%

Drawn debt

(66.6)

(5.2)%

Co-investment Incentive Scheme Accrual

(44.4)

(3.5)%

Other net current liabilities

(3.2)

(0.3)%

Net assets

1,272.6

100.0%

Our policy is to be fully invested through the cycle, while ensuring that we have sufficient financial resources to be able to meet existing obligations and take advantage of attractive investment opportunities as they arise.

The Company utilises a €300m (£260m) credit facility to enhance balance sheet flexibility. During the year the credit facility was extended by one year and matures in May 2029.

At 31 January 2026, ICG Enterprise Trust had a cash balance of £33.8m (31 January 2025: £3.9m) and total available liquidity of £227.1m (31 January 2025: £124.6m).

 

£m

Cash at 31 January 2025

3.9

Total Proceeds

382.3

New investments

(194.2)

Debt repaid

(73.6)

Dividends and buybacks

(51.3)

Management fees

(16.2)

FX and other expenses

(17.1)

Cash at 31 January 2026

33.8

Available undrawn debt facilities

193.3

Total available liquidity

227.1

Dividend and share buyback

ICG Enterprise Trust has a progressive dividend policy alongside two share buyback programmes to return capital to shareholders. In total ICGT returned £51m to shareholders in FY26 through dividends and buybacks.

Dividends

The Board has proposed a dividend of 12p per share in respect of the fourth quarter, taking total dividends for the year to 39p (FY25: 36p). This is the 13th consecutive year in which ordinary dividend per share increased.

Share Buybacks

The following purchases have been made under the Company's share buyback programmes:

 

Long-term

Opportunistic

Total

 

FY263

Since inception1

FY263

Since inception2

FY263

Since
inception

Number of shares purchased

1,007,501

3,754,189

1,031,221

2,523,396

2,038,722

6,277,585

% of opening shares since buyback started

 

 

 

 

 

9.2%

Capital returned to shareholders through buybacks

£13.9m

£46.4m

£13.9m

£32.2m

£27.8m

£78.6m

Number of days shares have been acquired

82

264

12

23

94

287

Weighted average discount to last reported NAV

31.7%

36.5%

32.8%

34.8%

32.3%

35.8%

NAV per Share accretion (p)

 

 

 

 

21.5

72.6

NAV per Share accretion (% of NAV)

 

 

 

 

1.1%

3.7%

  1. Since October 2022 (which was when the long-term share buyback programme was launched) up to and including 31 January 2026.

  2. Since May 2024 (which was when the opportunistic buyback programme was launched) up to and including 31 January 2026.

  3. Based on date of settlement.

Note: aggregate consideration excludes commission, PTM and SDRT.

The Board believes the long-term buyback programme demonstrates the Manager’s discipline around capital allocation; underlines the Board’s confidence in the long-term prospects of the Company, its cash flows and NAV; will enhance the NAV per Share; and, over time, may positively influence the volatility of the Company’s discount and its trading liquidity. The Board reconfirms the long-term share buyback programme is intended to operate at any discount to NAV.

The opportunistic buyback programme is intended to enable us to take advantage of attractive trading levels when we have the ability to purchase a meaningful number of shares. The size of the opportunistic buyback programme will be subject to a number of considerations, including the availability of shares and our cash flow experience and expectations.

The Board has renewed both long-term and opportunistic buyback programmes for FY27, with the opportunistic buyback sized at up to £25m.

Foreign exchange rates

The details of relevant foreign exchange rates applied in this report are provided in the table below:

 

Average rate for FY26

Average rate for FY25

31 January 2026 year end

31 January 2025 year end

GBP:EUR

1.16

1.18

1.15

1.20

GBP:USD

1.33

1.28

1.37

1.24

EUR:USD

1.14

1.08

1.19

1.04

Activity since the period end

Notable activity between 1 February 2026 and 31 March 2026 has included:

  • 2 new Fund Commitments for a combined value of £30m

  • Total New Investments of £17m

  • Total Proceeds of £27m

From 1 February 2026 up to and including 30 April 2026, 942,647 shares £13.7m were bought back at a weighted-average discount to NAV of 29.9%.

Post Period-end: Volatility In Public Market Software Companies

Post period-end, public market software companies experienced increased share price volatility amid concerns over the impact of Artificial Intelligence (‘AI’) on the sector.

The investment team’s view is that, in general, software companies can be very attractive investments. Business models are characterised by high margins, sticky recurring revenues, low capital intensity and structural growth driven by digitalisation. The understandably strong investor appetite drove software valuations to become elevated and, in our view, unsupportable. Over the past six years, ICGT has taken a disciplined approach to software investing, declining opportunities in several high-quality companies where valuations were considered unsustainable.

As a result, ICGT’s software exposure is 12%, which we believe is below the private market average. This exposure is focused on mission-critical businesses in areas such as accounting, payroll and compliance, which we consider resilient and, in every case, we only invested after stress-testing the impact of reduced exit valuations.

Looking ahead, we believe a number of our software companies are well-positioned to benefit from AI, particularly those with deterministic products and deep domain expertise.

The average EV/EBITDA multiple of our software investments at year-end was 21.6x. By comparison1, the S&P 500 Software Industry Index stood at 27x at the start of 2026.

As public market movements feed through to private valuations over the coming quarters, we believe ICGT’s limited exposure, the quality of the existing software companies and our disciplined approach should continue to support portfolio resilience.

ICG Private Equity Funds Investments Team

6 May 2026

  1. Indicative software index, noting differences in size and composition of software company

SUPPLEMENTARY INFORMATION

This section presents supplementary information regarding the Portfolio (see Manager’s Review and the Glossary for further details and definitions).

Portfolio composition

Portfolio by calendar year of investment

% of value of underlying investments
31 January 2026

% of value of underlying investments
31 January 2025

2026

0.7%

—%

2025

9.7%

0.5%

2024

12.5%

10.1%

2023

8.5%

7.6%

2022

19.7%

18.5%

2021

22.3%

25.7%

2020

7.9%

8.6%

2019

8.2%

10.3%

2018

2.9%

7.3%

2017 and older

7.6%

11.4%

Total

100.0%

100.0%


Portfolio by sector

% of value of underlying investments
31 January 2026

% of value of underlying investments
31 January 2025

TMT

30.1%

29.9%

Consumer goods and services

14.5%

18.1%

Healthcare

12.6%

11.5%

Business services

11.0%

12.4%

Financials

10.6%

7.8%

Industrials

10.3%

7.6%

Education

5.1%

5.0%

Leisure

2.3%

4.0%

Other

3.5%

3.7%

Total

100.0%

100.0%


Portfolio by fund currency1

£m

31 January 2026
%

31 January 2025
£m

31 January 2025
%

USD

771

57.0%

796

52.4%

EUR

478

35.3%

584

38.4%

GBP

104

7.7%

140

9.2%

Total

1,353

100.0%

1,520

100.0%

1 Currency exposure by reference to the reporting currency of each fund .

Portfolio Dashboard

The tables below provide disclosure on the composition and dispersion of financial and operational performance for the Top 30 and the Enlarged Perimeter. At 31 January 2026, the Top 30 Companies represented 36.9% of the Portfolio by value and the Enlarged Perimeter represented 69.6% of total Portfolio value. This information is prepared on a value-weighted basis, based on contribution to Portfolio value at 31 January 2026. Datasets for Top 30 companies and ‘Enlarged perimeter’ are not distinct and will have some overlap.

 

% of value at 31 January 2026

Sector exposure

Top 30

Enlarged Perimeter

TMT

34.2%

31.2%

Industrials

14.1%

14.3%

Consumer goods and services

11.5%

13.1%

Business services

16.8%

13.1%

Healthcare

14.2%

12.8%

Leisure

2.8%

3.2%

Education

6.4%

6.1%

Financials

—%

3.3%

Other

—%

3.0%

Total

100.0%

100.0%


 

% of value at 31 January 2026

Geographic exposure1

Top 30

Enlarged Perimeter

North America

48.6%

48.0%

Europe

48.4%

49.5%

Other

3.0%

2.5%

Total

100.0%

100.0%

1 Geographic exposure is calculated by reference to the location of the headquarters of the underlying Portfolio companies


 

% of value at 31 January 2026

LTM revenue growth

Top 30

Enlarged Perimeter

<0%

10.5%

16.7%

0-10%

40.6%

36.2%

10-20%

34.6%

26.8%

20-30%

9.3%

7.1%

>30%

5.0%

7.0%

n.a.

—%

6.3%

Weighted average

10.2%

9.5%

Note: for consistency, any excluded investments are excluded for all dispersion analysis.


 

% of value at 31 January 2026

LTM EBITDA growth

Top 30

Enlarged Perimeter

<0%

11.6%

15.6%

0-10%

35.5%

30.3%

10-20%

18.5%

19.5%

20-30%

17.8%

12.0%

>30%

16.7%

15.6%

n.a.

—%

6.9%

Weighted average

13.9%

13.1%

Note: for consistency, any excluded investments are excluded for all dispersion analysis.


 

% of value at 31 January 2026

EV/EBITDA multiple

Top 30

Enlarged Perimeter

0-10x

7.8%

9.1%

10-12x

10.1%

14.5%

12-13x

10.9%

9.3%

13-15x

23.7%

16.5%

15-17x

15.8%

15.5%

17-20x

8.5%

8.1%

>20x

21.2%

19.7%

n.a.

2.0%

7.3%

Weighted average

15.9x

15.7x

Note: for consistency, any excluded investments are excluded for all dispersion analysis.


 

% of value at 31 January 2026

Net Debt / EBITDA

Top 30

Enlarged Perimeter

<2x

16.2%

12.5%

2-4x

8.8%

13.8%

4-5x

26.0%

22.1%

5-6x

20.0%

17.5%

6-7x

23.2%

18.9%

>7x

5.8%

7.9%

n.a.

—%

7.3%

Weighted average

4.7x

4.8x

Note: for consistency, any excluded investments are excluded for all dispersion analysis.

Top 30 companies
The table below presents the 30 companies in which ICG Enterprise Trust had the largest investments by value at 31 January 2026. The valuations are gross of underlying managers’ fees and carried interest.

 

Company

Manager

Year of investment

Country

Value as a % of Portfolio

1

Circana

 

 

 

 

 

Provider of mission-critical data and predictive analytics to consumer goods manufacturers

New Mountain

2022

United States

2.1%

2

Visma

 

 

 

 

 

Provider of business management software and outsourcing services

Hg /
ICG

2017/ 2020 / 2024

Norway

2.0%

3

Leaf Home Solutions

 

 

 

 

 

Provider of home maintenance services

Gridiron

2016 / 2025

United States

1.8%

4

Curium Pharma

 

 

 

 

 

Supplier of nuclear medicine diagnostic pharmaceuticals

ICG

2020

United Kingdom

1.8%

5

Exail

 

 

 

 

 

Provider of autonomous systems for the aerospace and maritime sectors

ICG

2022

France

1.7%

6

Davies Group

 

 

 

 

 

Provider of speciality business process outsourcing services

BC

2021

United Kingdom

1.6%

7

Crucial Learning

 

 

 

 

 

Provider of corporate training courses focused on communication skills and leadership development

Leeds Equity

2019

United States

1.4%

8

Vistage

 

 

 

 

 

Provider of CEO leadership and coaching for small and mid-size businesses in the US

Gridiron

2022

United States

1.4%

9

Ambassador Theatre Group

 

 

 

 

 

Operator of theatres and ticketing platforms

ICG

2021

United Kingdom

1.4%

10

Precisely

 

 

 

 

 

Provider of enterprise software

Clearlake /
ICG

2021 / 2022

United States

1.3%

11

KronosNet

 

 

 

 

 

Provider of tech-enabled customer engagement and business solutions

ICG

2022

Spain

1.3%

12

Minimax

 

 

 

 

 

Supplier of fire protection systems and services

ICG

2018 / 2024 / 2025

Germany

1.3%

13

Chewy

 

 

 

 

 

Online retailer of pet food and products

BC

2014 / 2015 / 2022

United States

1.2%

14

Planet Payment

 

 

 

 

 

Provider of integrated payments services focused on hospitality and luxury retail

Eurazeo /
ICG

2021

Ireland

1.2%

15

Audiotonix

 

 

 

 

 

Manufacturer of audio mixing consoles

PAI

2024

United Kingdom

1.1%

16

Class Valuation

 

 

 

 

 

Provider of residential mortgage appraisal management services

Gridiron

2021

United States

1.1%

17

Yudo

 

 

 

 

 

Designer and manufacturer of hot runner systems

ICG

2017 / 2018

South Korea

1.1%

18

DigiCert

 

 

 

 

 

Provider of enterprise security solutions

ICG

2021

United States

1.1%

19

DomusVi

 

 

 

 

 

Operator of nursing homes

ICG

2017 / 2021

France

1.1%

20

Brooks Automation

 

 

 

 

 

Provider of semiconductor manufacturing solutions

TH Lee

2021 / 2022

United States

1.0%

21

European Camping Group

 

 

 

 

 

Operator of premium campsites and holiday
parks

PAI

2021 / 2022 / 2023 / 2025

France

1.0%

22

Multiversity

 

 

 

 

 

Provider of online higher education

CVC /
ICG

2024

Italy

0.9%

23

Ping Identity

 

 

 

 

 

Provider of cyber security solutions

Thoma Bravo

2022 / 2023

United States

0.9%

24

Datavant

 

 

 

 

 

Provider of healthcare data

ICG

2023

United States

0.9%

25

Archer

 

 

 

 

 

Developer of governance, risk and compliance software intended for risk management

Cinven

2023

United States

0.9%

26

Newton

 

 

 

 

 

Provider of management consulting services

ICG

2021 / 2022

United Kingdom

0.8%

27

Dayforce

 

 

 

 

 

Provider of human capital management solutions

Thoma Bravo

2026

United States

0.8%

28

Global Market Foods

 

 

 

 

 

Speciality distributor of international foods

Audax

2026

United States

0.8%

29

AMEOS Group

 

 

 

 

 

Operator of private hospitals

ICG

2021

Switzerland

0.8%

30

Avid Bioservices

 

 

 

 

 

Provider of biologic drug development and manufacturing services

GHO

2025

United States

0.7%

 

Total of the 30 largest underlying investments

 

 

 

36.9%

The 30 largest fund investments

The table below presents the 30 largest fund investments by value at 31 January 2026. The valuations are net of underlying managers’ fees and carried interest.

 

Fund

Year of commitment

Value £m

Outstanding commitment £m

1

ICG Strategic Equities Fund IV

 

 

 

 

GP-led secondary transactions

2021

34.1

5.6

2

ICG Europe VIII

 

 

 

 

Mezzanine and equity in mid-market buyouts

2021

32.3

11.2

3

ICG Strategic Equities Fund III

 

 

 

 

GP-led secondary transactions

2018

21.7

10.2

4

CVC European Equity Partners VII

 

 

 

 

Large buyouts

2017

21.3

3.1

5

ICG LP Secondaries Fund I LP

 

 

 

 

LP-led secondary transactions

2022

21.1

28.4

6

Gridiron Capital Fund III

 

 

 

 

Mid-market buyouts

2016

20.1

1.2

7

Seventh Cinven

 

 

 

 

Large buyouts

2019

19.8

1.7

8

PAI Europe VII

 

 

 

 

Mid-market and large buyouts

2017

18.5

1.5

9

ICG Ludgate Hill (Feeder B)

 

 

 

 

Secondary portfolio

2021

18.4

14.1

10

ICG Strategic Equities Fund V

 

 

 

 

GP-led secondary transactions

2023

17.9

26.9

11

Oak Hill V

 

 

 

 

Mid-market buyouts

2019

17.6

0.5

12

ICG Ludgate Hill (Feeder) Domino

 

 

 

 

Secondary portfolio

2025

17.4

4.0

13

Resolute V

 

 

 

 

Mid-market buy-outs

2021

17.1

0.6

14

Investindustrial VII

 

 

 

 

Mid-market buyouts

2019

16.3

4.1

15

ICG Augusta Partners Co-Investor**

 

 

 

 

Secondary fund restructurings

2018

16.2

15.8

16

Gridiron Capital Fund V

 

 

 

 

Mid-market buyouts

2022

15.0

1.7

17

Graphite Capital Partners VIII*

 

 

 

 

Mid-market buyouts

2013

14.7

4.1

18

Tailwind Capital Partners III

 

 

 

 

Mid-market buyouts

2018

14.6

1.1

19

Advent Global Private Equity IX

 

 

 

 

Large buyouts

2019

14.6

0.5

20

CVC Capital Partners VIII

 

 

 

 

Large buyouts

2020

14.6

0.5

21

ICG Ludgate Hill III

 

 

 

 

Secondary portfolio

2022

14.6

5.2

22

Graphite Capital Partners IX

 

 

 

 

Mid-market buyouts

2018

14.5

0.9

23

ICG Ludgate Hill (Feeder) II Boston SCSp

 

 

 

 

Secondary portfolio

2022

13.9

4.9

24

Gridiron Capital Fund IV

 

 

 

 

Mid-market buyouts

2019

13.5

0.4

25

Advent Global Private Equity X

 

 

 

 

Large buyouts

2022

13.3

6.5

26

New Mountain Partners VI

 

 

 

 

Mid-market buy-outs

2020

13.2

1.6

27

ICG Europe VII

 

 

 

 

Mezzanine and equity in mid-market buyouts

2018

12.9

5.9

28

Thomas H Lee Equity Fund IX

 

 

 

 

Mid-market and large buyouts

2021

12.8

3.3

29

Bowmark Capital Partners VI

 

 

 

 

Mid-market buyouts

2018

12.6

4.0

30

ICG Europe Mid-Market Fund

 

 

 

 

Mezzanine and equity in mid-market buyouts

2019

12.4

5.0

 

Total of the largest 30 fund investments

 

517.2

174.3

 

Percentage of total investment Portfolio

 

38.2%

 

* Includes the associated Top Up funds.

** All or part of interest acquired through a secondary sale.

HOW WE MANAGE RISK

Identifying and evaluating the strategic, financial and operational impact of our key risks

The execution of the Company’s investment strategy is subject to a variety of risks and uncertainties, and the Board and Manager have identified several principal risks to the Company’s business.

As part of this process, the Board has put in place an ongoing process to identify, assess and monitor the principal and emerging risks facing the Company, including those that would threaten its business model, future performance, solvency or liquidity.

RISK MANAGEMENT FRAMEWORK

The Board is responsible for risk management and determining the Company’s overall risk appetite. The Audit Committee assesses and monitors the risk management framework and specifically reviews the controls and assurance programmes in place.

Principal Risks

The Company’s principal risks are individual risks, or a combination of risks, that could threaten the Company’s business model, future performance, solvency or liquidity.

Details of the Company’s principal risks, potential impact, controls and mitigating factors are set out on pages 23 to 26.

Other Risks

Other risks, including reputational risk, are actively managed and mitigated as part of the wider risk management framework of the Company and the Manager.

Emerging Risks

Emerging risks are considered by the Board and are regularly assessed to identify any potential impact on the Company and to determine whether any actions are required. Emerging risks often arise from regulatory, legislative, macro-economic and political changes.

The Company depends upon the experience, skill and reputation of the employees of the Manager. The Manager’s ability to retain the services of these individuals, who are not obligated to remain employed by the Manager, and recruit successfully, is a significant factor in the success of the Company.

PRINCIPAL RISKS AND UNCERTAINTIES

The Company considers its principal risks (as well as several underlying risks comprising each principal risk) in four categories:

1.   Investment risks

The risk to performance resulting from ineffective or inappropriate investment selection, execution or monitoring.

2.   External risks

The risk of failing to deliver the Company’s investment objective and strategic goals due to external factors beyond the Company’s control.

3.   Operational risks

The risk of loss resulting from inadequate or failed internal processes, people or systems and external events, including regulatory risk.

4.   Financial risks

The risk of adverse impact on the Company due to having insufficient resources to meet its obligations or counterparty failure and the impact any material movement in foreign exchange rates may have on underlying valuations.

RISK ASSESSMENT PROCESS

A comprehensive risk assessment process is undertaken regularly to re-evaluate the impact and probability of each risk materialising and the strategic, financial and operational impact of the risk. Where the residual risk is determined to be outside appetite, appropriate action is taken. Further information on risk factors is set out within the financial statements.

Risk Appetite And Tolerance

The Board acknowledges and recognises that in the normal course of business, the Company is exposed to risk and it is willing to accept a certain level of risk in managing the business to achieve its targeted returns. The Board’s risk appetite framework provides a basis for the ongoing monitoring of risks and enables dialogue with respect to the Company’s current and evolving risk profile, allowing strategic and financial decisions to be made on an informed basis.

The Board considers several factors to determine its acceptance for each principal risk and categorises acceptance for each risk as low, moderate and high.

Where a risk is approaching or is outside the tolerance set, the Board will consider the appropriateness of actions being taken to manage the risk. In particular, the Board has a lower tolerance for financing risk with the aim to ensure that even under a stress scenario, the Company is likely to meet its funding requirements and financial obligations. Similarly, the Board has a low risk tolerance concerning operational risks including legal, tax and regulatory compliance and business process and continuity risk.

How we manage and mitigate our key risks

RISK

IMPACT

MITIGATION

CHANGE IN THE YEAR

INVESTMENT RISKS

 

 

 

INVESTMENT PERFORMANCE

The Manager selects the fund investments and Direct Investments for the Company’s Portfolio, executing the investment strategy approved by the Board. The underlying managers of those funds in turn select individual investee companies. The origination, investment selection and management capabilities of both the Manager and the third-party managers are key to the performance of the Company.

Poor origination, investment selection and monitoring by the Manager and/or third-party managers which may have a negative impact on Portfolio performance.

The Manager has a strong track record of investing in private equity through multiple economic cycles. The Manager has a highly selective investment approach and disciplined process, which is overseen by ICG Enterprise Trust’s Investment Committee within the Manager, which comprises a balance of skills and perspectives.
Further, the Company’s Portfolio is diversified, reducing the likelihood of a single investment decision impacting Portfolio performance.

STABLE
The Board is responsible for ensuring that the investment policy is met. The day-to-day management of the Company’s assets is delegated to the Manager under investment guidelines determined by the Board. The Board regularly reviews these guidelines to ensure they remain appropriate and monitors compliance with the guidelines through regular reports from the Manager, including performance reporting. The Board also reviews the investment strategy at least annually.
Following this assessment and other considerations, the Board concluded that investment performance risk has remained stable.

VALUATION

In valuing its investments in private equity funds and unquoted companies and publishing its NAV, the Company relies to a significant extent on the accuracy of financial and other information provided by the underlying managers to the Manager. There is the potential for inconsistency in the valuation methods adopted by the managers of these funds and companies and for valuations to be misstated.

Incorrect valuations being provided would lead to an incorrect overall NAV.

The Manager carries out a formal valuation process quarterly including a review of third-party valuations.

This process includes a comparison of unaudited valuations to latest audited reports, as well as a review of any potential adjustments that are required to ensure the valuations of the underlying investments are in accordance with the fair market value principles required under UK-adopted International Accounting Standards (‘IAS’).

STABLE

The Board regularly reviews and discusses the valuation process in detail with the Manager, including the sources of valuation information and methodologies used.

Following this assessment and other considerations, the Board concluded that there was no material change in valuation risk.

EXTERNAL RISKS

 

 

 

POLITICAL AND MACRO-ECONOMIC UNCERTAINTY

Political and macro-economic uncertainty and other global events, such as pandemics and conflicts, that are outside the Company’s control could adversely impact the environment in which the Company and its investment portfolio companies operate.

Changes in the political or macro-economic environment could significantly affect the performance of existing investments (and valuations) and prospects for realisations. In addition, they could impact the number of credible investment opportunities the Company can originate.

The Manager uses a range of complementary approaches to inform strategic planning and risk mitigation, including active investment management, profitability and balance sheet scenario planning and stress testing to ensure resilience across a range of outcomes.
The process is supported by a dedicated in-house economist and professional advisers where appropriate.

INCREASING

The Board monitors and reviews the potential impact on the Company from political and economic developments on an ongoing basis, including input and discussions with the Manager.

Incorporating these views and other considerations, the Board concluded that this risk had increased.

CLIMATE CHANGE

The underlying managers of the fund investments and Direct Investments in the Company’s Portfolio fail to ensure that their portfolio companies respond to the emerging threats from climate change.

Climate-related transition risks, driven in particular by abrupt shifts in the political and technological landscape, impact the value of the Company’s Portfolio.

The Manager has a well-defined, firm-wide Responsible Investing Policy and sustainable investing framework in place.

A tailored sustainable investing framework applies across all stages of the Company’s investment process.

STABLE

The Board monitors and reviews the potential impact to the Company from failures by underlying managers to mitigate the impact of climate change on portfolio company valuation.

THE LISTED PRIVATE EQUITY SECTOR

The listed private equity sector could fall out of favour with investors leading to a reduction in demand for the Company’s shares.

A change in sentiment to the sector has the potential to damage the Company’s reputation and impact the performance of the Company’s share price and widen the discount the shares trade at relative to NAV per Share, causing shareholder dissatisfaction.

Private equity continues to outperform public markets over the long term and has proved to be an attractive asset class through various cycles. The Manager is active in marketing the Company’s shares to a wide variety of investors to ensure the market is informed about the Company’s performance and investment proposition.

In setting the capital allocation policy, including the allocations to dividends and share buybacks, the Board monitors the discount to NAV and considers appropriate solutions to address any ongoing or substantial discount to NAV.

STABLE

The Board receives regular updates from the Company’s broker and is kept informed of all material discussions with investors and analysts.

FOREIGN EXCHANGE
The Company has continued to expand its geographic diversity by making investments in different countries. Accordingly, most investments are denominated in US dollars and euros.

The Company does not hedge its foreign exchange exposure. Therefore, movements in exchange rates between these currencies may have a material effect on the underlying sterling valuations of the investments and performance of the Company.

The Board regularly reviews the Company’s exposure to currency risk and reconsiders possible hedging strategies on at least an annual basis. Furthermore, the Company’s multicurrency bank facility permits the borrowings to be drawn in euros and US dollars, as required.

STABLE
The Board reviewed the Company’s exposure to currency risk and possible hedging strategies and concluded that there was no material change in foreign exchange risk during the year and that it remains appropriate for the Company not to hedge its foreign exchange exposure.

OPERATIONAL RISKS

 

 

 

REGULATORY, LEGAL AND TAX COMPLIANCE
Failure by the Manager to comply with relevant regulation and legislation could have an adverse impact on the Company. Additionally, adherence to changes in the legal, regulatory and tax framework applicable to the Manager could become onerous, lessening competitive or market opportunities.

The failure of the Manager and the Company to comply with the rules of professional conduct and relevant laws and regulations could expose the Company to regulatory sanction and penalties as well as significant damage to its reputation.

The Board is responsible for ensuring the Company’s compliance with all applicable regulatory, legal and tax requirements. Monitoring of this compliance has been delegated to the Manager, of which the in-house Legal, Compliance and Risk functions provide regular updates to the Board covering relevant changes to regulation and legislation.
The Board and the Manager continually monitor regulatory, legislative and tax developments to ensure early engagement in any areas of potential change.

STABLE
The Company remains responsive to a wide range of developing regulatory areas; and will continue to enhance its processes and controls in order to remain compliant with current and expected legislation.

KEY PROFESSIONALS
Loss of key professionals at the Manager could impair the Company’s ability to deliver its investment strategy and meet its external obligations if replacements are not found in a timely manner.

If the Manager’s team is not able to deliver its objectives, investment opportunities could be missed or misevaluated, while existing investment performance may suffer.

The Board has frequent dialogue with the Manager about its resourcing model and succession planning. The Manager employs an active and comprehensive approach to attract, retain and develop talent. This includes a well-defined recruitment process, succession planning, competitive long-term compensation and incentives.

STABLE
The Board reviewed the Company’s exposure to people risk and concluded that the Manager continues to operate sustainable succession, competitive remuneration and retention plans.
The Board believes that the risk in respect of people remains stable.

THE MANAGER AND THIRD-PARTY PROVIDERS (INCLUDING BUSINESS PROCESSES, BUSINESS CONTINUITY AND CYBER)
The Company is dependent on third parties for the provision of services and systems, especially those of the Manager, the Administrator and the Depositary.

Failure by a third-party provider to deliver services in accordance with its contractual obligations could disrupt or compromise the functioning of the Company. A material loss of service could result in, among other things, an inability to perform business critical functions, financial loss, legal liability, regulatory censure and reputational damage.
The failure of the Manager and Administrator to deliver an appropriate cyber security platform for critical technology systems could result in unauthorised access by malicious third parties, breaching the confidentiality, integrity and availability of Company data, negatively impacting the Company’s reputation.

The Audit Committee formally assesses the internal controls of the Manager, the Administrator and Depositary on an annual basis to ensure adequate controls are in place.
The assessment in respect of the current year is discussed in the Report of the Audit Committee.
The Management Agreement and agreements with other third-party service providers are subject to notice periods that are designed to provide the Board with adequate time to put in place alternative arrangements.

STABLE
The Board carries out a formal annual assessment (supported by the Manager’s internal audit function) of the Manager’s internal controls and risk management systems.
The Board also received regular reporting from the Manager and other third parties.
Following this review and other considerations, the Board concluded that there was no material change in the Manager and other third-party suppliers risk.

FINANCIAL RISKS

 

 

 

FINANCING
The Company has outstanding commitments to private equity funds in excess of total liquidity that may be drawn down at any time. The ability to fund this difference is dependent on receiving cash proceeds from investments (the timing of which are unpredictable) and the availability of financing facilities.

If the Company encountered difficulties in meeting its outstanding commitments, there would be significant reputational damage as well as risk of damages being claimed from managers and other counterparties.

The Manager monitors the Company’s liquidity, overcommitment ratio and covenants on a frequent basis, and undertakes cash flow monitoring, and provides regular updates on these activities to the Board.

STABLE
The Board reviewed the Company’s exposure to financing risk, noting the Net Debt position, the increase in available liquidity and the short-term realisation forecast, and concluded that this risk was stable.

Audited Financial Statements for the year ended 31 January 2026

INCOME STATEMENT

Year to 31 January 2026

Year to 31 January 2025

 

Notes

Revenue
return
£’000

Capital return
£’000

Total
£’000

Revenue
return
£’000

Capital return
£’000

Total
£’000

Investment returns

 

 

 

 

 

 

 

Income, gains and losses on investments

2, 10

2,306

13,584

15,890

1,060

134,156

135,216

Deposit interest

2

196

196

48

48

Other income

2

63

63

5

5

Foreign exchange gains and losses

 

3,533

3,533

(729)

(729)

 

 

2,565

17,117

19,682

1,113

133,427

134,540

Expenses

 

 

 

 

 

 

 

Investment management charges

3

(1,606)

(14,457)

(16,063)

(1,618)

(14,558)

(16,175)

Other expenses including finance costs

4

(3,198)

(8,850)

(12,048)

(2,439)

(8,417)

(10,856)

 

 

(4,804)

(23,307)

(28,111)

(4,057)

(22,975)

(27,031)

 

 

 

 

 

 

 

 

Profit/(loss) before tax

 

(2,239)

(6,190)

(8,429)

(2,943)

110,453

107,510

Taxation

6

Profit/(loss) for the period

 

(2,239)

(6,190)

(8,429)

(2,943)

110,453

107,510

Attributable to:

 

 

 

 

 

 

 

Equity shareholders

 

(2,239)

(6,190)

(8,429)

(2,943)

110,453

107,510

Basic and diluted earnings per share

7

 

 

(13.35)p

 

 

163.95p

 

 

 

 

 

 

 

 

The columns headed ‘Total’ represent the income statement for the relevant financial years and the columns headed ‘Revenue return’ and ‘Capital return’ are supplementary information in line with guidance published by the AIC. There is no Other Comprehensive Income.

All profits are from continuing operations.

The notes on pages 32 to 54 form an integral part of the financial statements.

BALANCE SHEET

 



Notes

31 January 2026
£'000

31 January 2025
£'000

Non-current assets

 

 

 

Investments held at fair value

9, 10, 17

1,308,900

1,469,549

 

 

 

 

Current assets

 

 

 

Cash and cash equivalents

11

33,837

3,927

Prepayments and receivables

12

1,486

2,018

 

 

35,323

5,945

Current liabilities

 

 

 

Borrowings

13

(66,570)

(131,931)

Payables

13

(5,081)

(11,171)

 

 

 

 

Net current liabilities

 

(36,328)

(137,157)

Total assets less current liabilities

 

1,272,572

1,332,392

 

 

 

 

Capital and reserves

 

 

 

Share capital

14

6,355

7,292

Capital redemption reserve

 

3,049

2,112

Share premium

 

12,936

12,936

Capital reserve

 

1,258,146

1,315,727

Revenue reserve

 

(7,914)

(5,675)

Total equity

 

1,272,572

1,332,392

 

 

 

 

Net Asset Value per Share (basic and diluted)

15

2044.6p

2072.9p

The notes on pages 32 to 54 form an integral part of the financial statements.

The financial statements on pages 28 to 54 were approved by the Board of Directors on 6 May 2026 and signed on its behalf by:

JaneTufnell        Alastair Bruce
Director                Director

CASH FLOW STATEMENT

 

Notes

Year to
31 January 2026
£'000

Year to
31 January 2025
£'000

Operating activities

 

 

 

Sale of portfolio investments

 

60,090

19,966

Purchase of portfolio investments

 

(50,605)

(34,144)

Cash flow to subsidiaries' investments

 

(154,775)

(152,174)

Cash flow from subsidiaries' investments

 

320,137

125,769

Interest income received from portfolio investments

 

708

494

Dividend income received from portfolio investments

 

1,452

547

Other income received

 

259

53

Investment management charges paid

 

(16,240)

(16,021)

Other expenses paid

 

(1,998)

(1,881)

Net cash inflow/(outflow) from operating activities

 

159,028

(57,391)

 

 

 

 

Financing activities

 

 

 

Bank facility fee paid

 

(2,572)

(2,011)

Interest paid

 

(6,492)

(545)

Credit facility utilised

 

126,608

139,761

Credit facility repaid

 

(196,875)

(27,831)

Purchase of shares into treasury

 

(27,987)

(35,851)

Equity dividends paid

8

(23,404)

(22,308)

Net cash (outflow)/inflow from financing activities

 

(130,722)

51,215

Net increase/(decrease) in cash and cash equivalents

 

28,306

(6,176)

 

 

 

 

Cash and cash equivalents at beginning of year

11

3,927

9,722

Net increase/(decrease) in cash and cash equivalents

 

28,306

(6,176)

Effect of changes in foreign exchange rates

 

1,604

381

Cash and cash equivalents at end of period

11

33,837

3,927

The notes on pages 32 to 54 form an integral part of the financial statements.

STATEMENT OF CHANGES IN EQUITY

 



Share capital
£’000

Capital
redemption
reserve
£’000



Share premium
£’000

Realised capital
reserve1
£’000

Unrealised capital
reserve
£’000

Revenue
reserve1
£’000

Total
shareholders’
equity
£’000

 

 

 

 

Opening balance at 1 February 2025

7,292

2,112

12,936

408,641

907,087

(5,675)

1,332,392

Profit for the period and total comprehensive income

37,556

(43,747)

(2,239)

(8,429)

Transfer to capital redemption reserve

(937)

937

Dividends paid or approved

(23,404)

(23,404)

Purchase of shares into treasury

(27,987)

(27,987)

Closing balance at 31 January 2026

6,355

3,049

12,936

394,806

863,340

(7,914)

1,272,572

 

 

 

 

 

 

 

 

 



Share capital
£’000

Capital redemption
reserve
£’000



Share premium
£’000

Realised capital
reserve1
£’000

Unrealised capital
reserve
£’000

Revenue
reserve1
£’000

Total
shareholders’
equity
£’000

 

 

 

 

Opening balance at 1 February 2024

7,292

2,112

12,936

473,015

790,602

(2,733)

1,283,223

Profit for the period and total comprehensive income

(6,033)

116,485

(2,942)

107,510

Dividends paid or approved

(22,308)

(22,308)

Purchase of shares into treasury

(36,033)

(36,033)

Closing balance at 31 January 2025

7,292

2,112

12,936

408,641

907,087

(5,675)

1,332,392

  1. Distributable reserves

The notes on pages 32 to 54 form an integral part of the financial statements.

1 MATERIAL ACCOUNTING POLICY INFORMATION

General information

These financial statements relate to ICG Enterprise Trust Plc (‘the Company’). ICG Enterprise Trust Plc is registered in England and Wales and is incorporated in the United Kingdom. The Company is domiciled in the United Kingdom and its registered office is Procession House, 55 Ludgate Hill, London EC4M 7JW. The Company’s objective is to provide long-term growth by investing in private companies managed by leading private equity managers.

(a) Basis of preparation

The financial information for the year ended 31 January 2026 has been prepared in accordance with UK-adopted International Accounting Standards (‘UK-IAS’) and the Statement of Recommended Practice (‘SORP’) for investment trusts issued by the Association of Investment Companies in July 2022.

UK-IAS comprises standards and interpretations approved by the International Accounting Standards Board (‘IASB’) and the IFRS Interpretations Committee.

These financial statements have been prepared on a going concern basis and on the historical cost basis of accounting, modified for the revaluation of certain assets at fair value. The directors have concluded that the preparation of the financial statements on a going concern basis continues to be appropriate.

Going concern

In assessing the appropriateness of continuing to adopt the going concern basis of accounting, the Board has assessed the financial position and prospects of the Company. The Company’s business activities, together with factors likely to affect its future development, performance, position and cash flows, are set out in the Chair’s statement on page 6, and the Manager’s review on page 8.

As part of this review, the Board assessed the potential impact of principal risks on the Company’s business activities, the Company’s cash position, the availability of the Company’s credit facility and compliance with its covenants, and the Company’s cash flow projections.

Based on this assessment, the Board expects that the Company will be able to continue in operation and meet its liabilities as they fall due until, at least, 31 May 2027, a period of more than 12 months from the signing of the financial statements. Therefore it is appropriate to continue to adopt the going concern basis of preparation of the Company’s financial statements.

Climate change

In preparing the financial statements, the directors have considered the impact of climate change, particularly in the context of the climate change risks identified in the Principal risks and uncertainties section of the Strategic Report, and the impact of climate change risk on the valuation of investments.

These considerations did not have a material impact on the financial reporting judgements and estimates in the current year, nor were they expected to have a significant impact on the Company’s going concern or viability.

Accounting policies

The principal accounting policies adopted are set out below. These policies have been applied consistently throughout the current and prior year. In order to reflect the activities of an investment trust company, supplementary information which analyses the income statement between items of revenue and capital nature has been presented alongside the income statement. In analysing total income between capital and revenue returns, the directors have followed the guidance contained in the SORP as follows:

Capital gains and losses on investments sold and on investments held arising on the revaluation or disposal of investments classified as held at fair value through profit or loss should be shown in the capital column of the income statement.

Returns on any share or debt security for a fixed amount (whether in respect of dividends, interest or otherwise) should be shown in the revenue column of the income statement.

The Board should determine whether the indirect costs of generating capital gains should also be shown in the capital column of the income statement. If the Board decides that this should be so, the management fee should be allocated between revenue and capital in accordance with the Board’s expected long-term split of returns, and other expenses should be charged to capital only to the extent that a clear connection with the maintenance or enhancement of the value of investments can be demonstrated.

The accounting policy regarding the allocation of expenses is set out in Note 1(j).

In accordance with IFRS 10 (amended), the Company is deemed to be an investment entity on the basis that:
(a) it obtains funds from one or more investors for the purpose of providing investors with investment management services;
(b) it commits to its investors that its business purpose is to invest funds for both returns from capital appreciation and investment income; and
(c) it measures and evaluates the performance of substantially all of its investments on a fair value basis.
As a result, the Company’s controlled structured entities (‘subsidiaries’) are deemed to be investments and are classified as held at fair value through profit and loss.

New and amended standards and interpretations

The Company adopts new standards, if applicable, when they become effective. There are no new standards that are expected to have a material impact on the Company. IFRS 18 Presentation and Disclosure in Financial Statements is not expected to have a material impact on the results or net assets of the Company, the impact on the presentation of the financial statements is still being assessed.

(b) Financial assets

The Company classifies its financial assets in the following categories: at fair value through profit or loss; and at amortised cost. The classification depends on the purpose for which the financial assets were acquired. The classification of financial assets is determined at initial recognition.

Financial assets at fair value through profit or loss

The Company classifies its quoted and unquoted investments as financial assets at fair value through profit or loss. These assets are measured at subsequent reporting dates at fair value and further details of the accounting policy are disclosed in Note 1(c).

Financial assets at amortised cost

Financial assets at amortised cost are non-derivative financial assets which pass the contractual cash flow test and are held to receive contractual cash flows. These are classified as current assets and measured at amortised cost using the effective interest rate method. The Company’s financial assets at amortised cost comprise cash and cash equivalents and trade and other receivables in the balance sheet.

(c) Investments

Investments comprise fund investments and portfolio company investments held by the Company directly, together with the fair value of the Company’s interest in controlled structured entities (see Note 9) which themselves invest in fund investments and portfolio company investments.

All investments are classified upon initial recognition as held at fair value through profit or loss (described in these financial statements as investments held at fair value) and are measured at subsequent reporting dates at fair value. All investments are fair valued in line with IFRS 13 ‘Fair Value Measurement’, using industry standard valuation guidelines such as the International Private Equity and Venture Capital (‘IPEV’) valuation guidelines. Changes in the value of all investments held at fair value, which include returns on those investments such as dividends and interest, are recognised in the income statement and are allocated to the revenue column or the capital column in accordance with the SORP (see Note 1(a)). More detail on certain categories of investment is set out below. Given that the subsidiaries and associates are held at fair value and are exposed to materially similar risks as the Company, we do not expect the risks to materially differ from those disclosed in Note 17.

Unquoted investments

Fund investments and Co-investments (collectively ‘unquoted investments’) are fair valued using the net asset value of those unquoted investments as determined by the investment manager of those funds. The investment manager perf...orms periodic valuations of the underlying investments in their funds, typically using earnings multiple or discounted cash flow methodologies to determine enterprise value in line with IPEV guidelines. In the absence of contrary information, these net asset valuations received from the investment managers are deemed to be appropriate by the Manager, for the purposes of the Manager’s determination of the fair values of the unquoted investments. A robust assessment is performed by the Manager’s experienced Investment Committee to determine the capability and track record of the investment manager. All investment managers are scrutinised by the Investment Committee and an approval process is recorded before any new investment manager is approved and an investment made. This level of scrutiny provides reasonable comfort that the investment manager’s valuation will be consistent with the requirement to use fair value.

Adjustments may be made to the net asset values provided or an alternative valuation method may be adopted if deemed to be more appropriate. The most common reason for adjustments to the value provided by an underlying manager is to take account of events occurring between the date of the manager’s valuation and the reporting date, for example, subsequent cash flows or notification of an agreed sale.

Subsidiary undertakings

The investments in the controlled structured entities (‘subsidiaries’) are recognised at fair value through profit and loss.

The valuation of the subsidiaries takes into account an accrual for the estimated value of interests in the Co-investment Incentive Scheme. Under these arrangements, ICG (the ‘Manager’) and certain of its executives and, in respect of certain historic investments, the executives and connected parties of Graphite Capital Management LLP (the ‘Former Manager’) (together ‘the Co-investors’), are required to co-invest alongside the Company, for which they are entitled to a share of investment profits if certain performance hurdles are met. At 31 January 2026, the accrual was estimated as the theoretical value of the interests if the Portfolio had been sold at the carrying value at that date.

Associates

The Company holds an interest (including indirectly through its subsidiaries) of more than 20% in a small number of investments that may normally be classified as subsidiaries or associates. These investments are not considered subsidiaries or associates as the Company does not exert control or significant influence over the activities of these companies/structured entities as they are managed by other third parties.

(d) Prepayments and receivables

Receivables include unamortised fees which were incurred directly in relation to the agreement of a financing facility. These fees will be amortised over the life of the facility on a straight-line basis.

(e) Borrowings

Borrowings drawdowns are recognised initially at cost being the fair value of the amounts received upon utilisation. They are subsequently stated at amortised cost.

(f) Payables

Other payables are non-interest bearing and are stated at their amortised cost, which is not materially different from fair value.

(g) Cash and cash equivalents

Cash and cash equivalents comprise cash and short-term bank deposits with an original maturity of three months or less.

(h) Dividend distributions

Dividend distributions to shareholders are recognised in the period in which they are paid.

(i) Income

When it is probable that economic benefits will flow to the Company and the amount can be measured reliably, interest is recognised on a time apportionment basis.

Dividends receivable on quoted equity shares are brought into account on the ex-dividend date. Dividends receivable on equity shares where no ex-dividend date is applicable are brought into account when the Company’s right to receive payment is established.

UK dividend income is recorded at the amount receivable. Overseas dividend income is shown net of withholding tax. Income distributions from funds are recognised when the right to distributions is established.

(j) Expenses

All expenses are accounted for on an accruals basis. Expenses are allocated to the revenue column in the income statement, consistent with the SORP, with the following exceptions:

  • Expenses which are incidental to the acquisition or disposal of investments (transaction costs) are allocated to the capital column.

  • The Board expects the majority of long-term returns from the Portfolio to be generated from capital gains. Expenses are allocated 90% to the capital column and 10% to the revenue column, reflecting the Company’s current and future return profile. Other expenses are allocated to the capital column where a clear connection with the maintenance or enhancement of the value of investments can be demonstrated.

  • All expenses allocated to the capital column are treated as realised capital losses (see Note 1(m).

(k) Taxation

Investment trusts which have approval as such under Section 1158 of the Corporation Tax Act 2010 are not liable for taxation on capital gains.

Tax recognised in the income statement represents the sum of current tax and deferred tax charged or credited in the year. The tax effect of different items of expenditure is allocated between capital and revenue on the same basis as the particular item to which it relates.

Deferred tax is the tax expected to be payable or recoverable on the difference between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method.

Deferred tax liabilities are recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Deferred tax assets are not recognised in respect of tax losses carried forward to future periods.

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the assets are realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

(l) Foreign currency translation

The functional and presentation currency of the Company is sterling, reflecting the primary economic environment in which the Company operates.

Transactions in currencies other than sterling are recorded at the rates of exchange prevailing on the dates of the transactions. At each balance sheet date, financial assets and liabilities denominated in foreign currencies are translated at the rates prevailing on the balance sheet date.

Gains and losses arising on the translation of investments held at fair value are included within gains and losses on investments held at fair value in the income statement. Gains and losses arising on the translation of other financial assets and liabilities are included within foreign exchange gains and losses in the income statement.

(m) Revenue and capital reserves

The revenue return component of total income is taken to the revenue reserve within the statement of changes in equity. The capital return component of total income is taken to the capital reserve within the statement of changes in equity.

Gains and losses on the realisation of investments including realised exchange gains and losses and expenses of a capital nature are taken to the realised capital reserve (see Note 1(j). Changes in the valuations of investments which are held at the year end and unrealised exchange differences are accounted for in the unrealised capital reserve.

Net gains on the realisation of investments in the controlled structured entities (see Note 9) are transferred to the Company by way of profit distributions.

The revenue reserve is distributable by way of dividends to shareholders. The realised capital reserve is distributable by way of dividends and share buybacks. The capital redemption reserve is not distributable and represents the nominal value of shares bought back for cancellation.

(n) Treasury shares

Shares that have been repurchased into treasury remain included in the share capital balance, unless they are cancelled.

(o) Critical estimates and assumptions

Estimates and judgements used in preparing the financial information are continually evaluated and are based on historic experience and other factors, including expectations of future events that are believed to be reasonable. The resulting estimates will, by definition, seldom equal the related actual results.

In preparing the financial statements, the directors have considered the impact of climate change on the key estimates within the financial statements.

The only estimates and assumptions that have a significant risk of causing a material adjustment to the carrying values of assets and liabilities in the next financial year relate to the valuation of unquoted investments. Unquoted investments are primarily the Company’s investments in unlisted funds, managed by investment fund managers and ICG. As such there is significant estimation in the valuation of the unlisted fund at a point in time. Note 1(c) sets out the accounting policy for unquoted investments. The carrying amount of unquoted investments at the year end is disclosed within Note 10.

(p) Segmental reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker who is responsible for allocating resources and assessing performance of the segments has been identified as the Board. It is considered that the Company’s operations comprise a single operating segment.

2 INVESTMENT RETURNS

 

Year ended

Year ended

 

31 January 2026

31 January 2025

 

£’000

£’000

Income from investments

 

 

Interest and dividends from investments

2,306

1,060

 

2,306

1,060

Deposit interest on cash

196

48

Other

63

5

 

259

53

Total income

2,565

1,113

Analysis of income from investments

 

 

Unquoted

2,306

1,060

 

2,306

1,060

3 INVESTMENT MANAGEMENT CHARGES

From 1 February 2023 the management fee has been subject to a cap of 1.25% of net asset value.

Management fees paid to ICG for managing ICG Enterprise Trust amounted to 1.25% (2025: 1.25%) of the average net assets in the year.

The amounts charged during the year are set out below:

 

Year ended 31 January 2026

Year ended 31 January 2025

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£’000

£’000

£’000

£’000

£’000

£’000

Investment management charge

1,606

14,457

16,063

1,617

14,558

16,175

The Company and its subsidiaries also incur management fees in respect of its investment in funds managed by members of ICG on an arms-length basis.

 

Year ended

Year ended

 

31 January 2026

31 January 2025

 

£’000

£’000

ICG Europe VIII

521

434

ICG Strategic Equity V

475

353

ICG Strategic Equity III

227

238

ICG Europe VII

217

238

ICG LP Secondaries Fund I LP

354

325

ICG Europe Mid-Market

427

87

ICG Strategic Equity IV

312

340

ICG Europe Mid-Market II

422

95

ICG Augusta Partners Co-Investor II

76

89

ICG North American Private Debt II

34

68

ICG Strategic Secondaries II

17

36

ICG Europe VI

20

23

ICG Asia Pacific III

13

15

ICG Recovery Fund 2008B

3

ICG Europe V

2

 

3,115

2,346

4 OTHER EXPENSES

The Company did not employ any staff in the year to 31 January 2026 (2025: none). Expenses are presented inclusive of irrecoverable VAT at a rate of 20%, where applicable.

 

Year ended

Year ended

 

31 January 2026

31 January 2025

 

£’000

£’000

£’000

£’000

Directors’ fees (see Note 5)

 

351

 

340

Fees payable to the Company’s auditor for the audit of the Company’s annual accounts1

373

 

170

 

Fees payable to the Company’s auditor and its associates for other services:

 

 

 

 

- Audit of the accounts of the subsidiaries

135

 

108

 

- Audit-related assurance services2

69

 

71

 

Total auditors’ remuneration

 

577

 

349

Administrative expenses

 

1,343

 

811

 

 

2,271

 

1,500

Bank facility costs allocated to revenue

 

289

 

277

Interest costs allocated to revenue

 

638

 

661

Expenses allocated to revenue

 

3,198

 

2,438

Bank facility costs allocated to capital

 

8,850

 

8,417

Total other expenses

 

12,048

 

10,855

 

 

 

 

 

1. The auditors’ remuneration for the year ended 31 January 2026 includes an under-accrual of £176k from the prior year.

2.The auditors have additionally provided £16k (2025: £16k) of non-audit related services permitted under the Financial Reporting Council’s (‘FRC’) Revised Ethical Standards. The service related to agreed upon procedures over the Company’s carried interest scheme.

Included within Total other expenses above are £9.8m (2025: £9.4m) of costs related to financing and £0.5m (2025: £0.2m credit) of other expenses which are non-recurring and are excluded from the Ongoing Charges as detailed in the Glossary on page 55.

Professional fees of £0.2m (2025: £0.2m) incidental to the acquisition or disposal of investments are included within gains/(losses) on investments held at fair value.

5 DIRECTORS’ REMUNERATION AND INTERESTS

No income was received or receivable by the directors from any other subsidiary of the Company.

6 TAXATION

In both the current and prior years the tax charge was lower than the standard rate of corporation tax of 25%, principally due to the Company’s status as an investment trust, which means that capital gains are not subject to corporation tax. The effect of this and other items affecting the tax charge are shown in Note 6(b) below:

 

Year ended

Year ended

 

31 January 2026

31 January 2025

 

£’000

£’000

a) Analysis of charge in the year

 

 

Tax credit on items allocated to revenue

Tax charge on items relating to prior years

Corporation tax

b) Factors affecting tax charge for the year

 

 

Profit on ordinary activities before tax

(8,429)

107,510

Profit before tax multiplied by rate of corporation tax in the UK of 25% (2025: 25%)

(2,108)

26,790

Effect of:

 

 

– net investment returns not subject to corporation tax

(4,279)

(33,357)

– dividends not subject to corporation tax

(363)

(52)

– expenses not deductible for tax purposes

1,588

1,353

– taxable allocation of income and expenses from partnerships

138

489

– current year management expenses not utilised/(utilised)

5,024

4,777

Total tax charge

The Company has £89.5m excess management expenses carried forward (2025: £70.0m). No deferred tax assets or liabilities (2025: nil) have been recognised in respect of the carried forward management expenses due to the uncertainty that future taxable profit will be generated that these losses can be offset against. For all investments the tax base is equal to the carrying amount. There was no deferred tax expense relating to the origination and reversal of timing differences in the year (2025: nil).

7 EARNINGS PER SHARE

 

Year ended

Year ended

 

31 January 2026

31 January 2025

Revenue return per ordinary share

(3.55p)

(4.49p)

Capital return per ordinary share

(9.80p)

168.38p

Earnings per ordinary share (basic and diluted)

(13.35)p

163.95p

Revenue return per ordinary share is calculated by dividing the revenue return attributable to equity shareholders of £(2.2)m (2025: £(2.9)m) by the weighted average number of ordinary shares outstanding during the year.

Capital return per ordinary share is calculated by dividing the capital return attributable to equity shareholders of £(6.2)m (2025: £110.4m) by the weighted average number of ordinary shares outstanding during the year.

Basic and diluted earnings per ordinary share are calculated by dividing the earnings attributable to equity shareholders of £(8.4)m (2025: £107.5m) by the weighted average number of ordinary shares outstanding during the year.

The weighted average number of ordinary shares outstanding (excluding those held in treasury) during the year was 63,153,044 (2025: 65,569,285). There were no potentially dilutive shares, such as options or warrants, in either year.

8 DIVIDENDS

 

Year ended

Year ended

 

31 January 2026

31 January 2025

 

£’000

£’000

Third quarterly dividend in respect of year ended 31 January 2025: 8.5p per share (2024: 8.0p)

5,460

5,345

Final dividend in respect of year ended 31 January 2025: 10.5p per share (2024: 9.0p)

6,625

5,894

First quarterly dividend in respect of year ended 31 January 2026: 9.0p per share (2025: 8.5p)

5,669

5,557

Second quarterly dividend in respect of year ended 31 January 2026: 9.0p per share (2025: 8.5p)

5,650

5,512

Total

23,404

22,308

The Company paid a third quarterly dividend of 9.0p per share in February 2026. The Board has proposed a final dividend of 12.0p per share (estimated cost £7.5m) in respect of the year ended 31 January 2026 which, if approved by shareholders, will be paid on 17 July 2026 to shareholders on the Register of Members at the close of business on 3 July 2026.

9 SUBSIDIARY UNDERTAKINGS AND UNCONSOLIDATED STRUCTURED ENTITIES

Subsidiary undertakings (controlled structured entities)

Subsidiaries of the Company as at 31 January 2026 comprise the following controlled structured entities, which are registered in England and Wales, ICG Lewis (Delaware) LLC is registered in Delaware,USA. Subsidiaries of the Company’s direct subsidiaries are reported as indirect subsidiaries.

Direct subsidiaries

 

Ownership interest 2026

Ownership interest 2025

ICG Enterprise Trust Limited Partnership

 

—%

97.5%

ICG Enterprise Trust (2) Limited Partnership

 

97.5%

97.5%

ICG Enterprise Trust Co-investment Limited Partnership

 

99.0%

99.0%


Indirect subsidiaries

 

Ownership interest 2026

Ownership interest 2025

ET Holdings LP

 

99.5%

99.5%

ICG Morse Partnership LP

 

99.5%

99.5%

ICG Lewis Partnership LP

 

99.5%

99.5%

ICG Lewis (Delaware) LLC

 

99.5%

—%

The ICG Enterprise Trust Limited Partnership was dissolved on 31 July 2025. ICG Lewis (Delaware) LLC was formed on 31 December 2025.

In accordance with IFRS 10 (amended), the subsidiaries are not consolidated and are instead included in unquoted investments at fair value.

The fair value of the investment in subsidiaries includes an accrual for the interests of the Co-investors (ICG and certain of its executives and in respect of certain historical investments, the executives and connected parties of Graphite Capital, the Former Manager) in the Co-investment Incentive Scheme. As at 31 January 2026, a total of £44.4m (2025: £53.9m) was accrued in respect of these interests. During the year the Co-investors invested £0.7m (2025: £1.0m) into ICG Enterprise Trust Co-investment Limited Partnership. Payments received by the Co-investors amounted to £11.9m or 3.1% of £382.3m of Total Proceeds received in the year (2025: £10.8m or 7.1% of £150.8m Total Proceeds received).

Unconsolidated structured entities

The Company’s principal activity is investing in private equity funds and directly into private companies. Such investments may be made and held via a subsidiary. The majority of these investments are unconsolidated structured entities as defined in IFRS 12.

The Company holds interests in closed-ended limited partnerships which invest in underlying companies for the purposes of capital appreciation. The Company and the other limited partners make commitments to finance the investment programme of the relevant manager, who will typically draw down the amount committed by the limited partners over a period of four to six years (see Note 16).

The table below disaggregates the Company’s interests in unconsolidated structured entities. The table presents for each category the related balances and the maximum exposure to loss.

 

Unquoted investments
£'000

Co-investment incentive scheme
accrual
£'000

Maximum loss exposure
£'000

As at 31 January 2026

1,353,292

(44,392)

1,308,900

As at 31 January 2025

1,523,459

(53,910)

1,469,549

Further details of the Company’s investment Portfolio are included in the Portfolio dashboard on page 16.

10 INVESTMENTS

The tables below analyse the movement in the carrying value of the Company’s investments in the year. In accordance with accounting standards, subsidiary undertakings of the Company are reported at fair value rather than on a ‘look-through’ basis.

An investee fund is considered to generate realised gains or losses if it is more than 85% drawn and has returned at least the amount invested by the Company. All gains and losses arising from the underlying investments of such funds are presented as realised. All gains and losses in respect of fund investments that have not satisfied the above criteria are presented as unrealised.

Direct Investments are considered to generate realised gains or losses when they are sold.

Investments are held by both the Company and through its subsidiaries.

 

Quoted

Unquoted

Subsidiary Undertakings

Total

 

£’000

£’000

£’000

£’000

Cost at 1 February 2025

193,458

325,637

519,095

Unrealised appreciation at 1 February 2025

111,771

838,683

950,454

Valuation at 1 February 2025

305,229

1,164,320

1,469,549

Movements in the year:

 

 

 

 

Purchases

50,606

154,590

205,196

Sales

 

 

 

 

– capital proceeds

(60,167)

(320,138)

(380,305)

– realised gains/(losses) based on carrying value at previous balance sheet date

(1,365)

(1,365)

Movement in unrealised appreciation

20,636

(4,811)

15,825

Valuation at 31 January 2026

314,939

993,961

1,308,900

Cost at 31 January 2026

183,897

160,089

343,986

Unrealised appreciation at 31 January 2026

131,042

833,872

964,914

Valuation at 31 January 2026

314,939

993,961

1,308,900

 

 

Quoted

Unquoted

Subsidiary Undertakings

Total

 

£’000

£’000

£’000

£’000

Cost at 1 February 2024

179,528

300,114

479,642

Unrealised appreciation at 1 February 2024

80,768

735,972

816,740

Valuation at 1 February 2024

260,296

1,036,086

1,296,382

Movements in the year:

 

 

 

 

Purchases

34,144

151,292

185,436

Sales

 

 

 

 

– capital proceeds

(20,214)

(125,769)

(145,983)

– realised gains based on carrying value at previous balance sheet date

1,530

1,530

Movement in unrealised appreciation

29,473

102,711

132,184

Valuation at 31 January 2025

305,229

1,164,320

1,469,549

Cost at 31 January 2025

193,458

325,637

519,095

Unrealised appreciation at 31 January 2025

111,771

838,683

950,454

Valuation at 31 January 2025

305,229

1,164,320

1,469,549


 

31 January 2026

31 January 2025

 

£’000

£’000

Realised (losses)/gains based on carrying values at previous balance sheet date

(1,365)

1,530

Increase in unrealised appreciation

15,825

132,184

Gains on investments

14,460

133,714

Gains on investments includes the ‘Realised loss based on carrying values at previous balance sheet date’, which meet the criteria set out on this page, together with the net fair value movement on the balance of the investee funds.

Related undertakings

At 31 January 2026, the Company held direct and indirect interests in five limited partnership and one limited liability company subsidiaries. These interests, net of the incentive accrual as described in Note 9, were:

Investment

31 January 2026
%

31 January 2025
%

ICG Enterprise Trust Limited Partnership

—%

99.9%

ICG Enterprise Trust (2) Limited Partnership

66.5%

66.5%

ICG Enterprise Trust Co-investment Limited Partnership

66.0%

66.0%

ICG Enterprise Holdings LP

99.5%

99.5%

ICG Morse Partnership LP

99.5%

99.5%

ICG Lewis (Delaware) LLC

99.5%

—%

ICG Lewis Partnership LP

99.5%

99.5%

The registered address of the limited liability company is The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801. The registered address and principal place of business of all other subsidiary partnerships is Procession House, 55 Ludgate Hill, London EC4M 7JW.

In addition, the Company held an interest (including indirectly through its subsidiaries) of more than 20% in the following entities. These investments are not considered subsidiaries or associates as the Company does not exert control or have significant influence over the activities of these companies/partnerships.

As at 31 January 2026

 

 

Investment

Instrument

% interest1

Graphite Capital Partners VII Top Up Plus2

Limited partnership interests

20.0%

Graphite Capital Partners VIII Top Up

Limited partnership interests

41.1%

ICG Velocity3

Limited partnership interests

42.9%

 

 

 

As at 31 January 2025

 

 

Investment

Instrument

% interest1

Graphite Capital Partners VII Top Up Plus2

Limited partnership interests

20.0%

Graphite Capital Partners VIII Top Up

Limited partnership interests

41.1%

ICG Velocity3

Limited partnership interests

32.5%

  1. The percentage shown for limited partnership interests represents the proportion of total commitments to the relevant fund. The percentage shown for shares represents the proportion of total shares in issue.

  2. Address of principal place of business is 7 Air Street, Soho, London W1B 5AD.

  3. Address of principal place of business is Procession House, 55 Ludgate Hill, London EC4M 7JW.

11 CASH AND CASH EQUIVALENTS

 

31 January 2026

31 January 2025

 

£’000

£’000

Cash at bank and in hand

33,837

3,927

12 PREPAYMENTS AND RECEIVABLES

 

31 January 2026

31 January 2025

 

£’000

£’000

Prepayments and accrued income

1,486

2,018

As at 31 January 2026, prepayments and accrued income included £1.1m (2025: £2.0m) of unamortised costs in relation to the bank facility. Of this amount £0.8m (2025: £0.8m) is expected to be amortised in less than one year.

13 PAYABLES – CURRENT

 

31 January 2026

31 January 2025

 

£’000

£’000

Accruals

5,081

11,171

Credit facility drawn

66,570

131,931

 

71,651

143,102

Bank facility details are shown in the Liquidity risk section of Note 17 on page 46.

14 SHARE CAPITAL

 

Authorised

Issued and fully paid

 

 

Nominal

 

Nominal

Equity share capital

Number

£’000

Number

£’000

Balance at 31 January 2026

120,000,000

12,000

63,554,192

6,355

Balance at 31 January 2025

120,000,000

12,000

72,913,000

7,292

All ordinary shares have a nominal value of 10.0p. At 31 January 2026 63,554,192 (2025: 72,913,000) shares had been allocated, called up and fully paid. During the year 2,032,722 shares were bought back in the market and held in treasury (2025: 2,932,675 shares). On the 30 April 2025 the Company cancelled 9,358,808 10p ordinary shares that were held in Treasury. Following the cancellation, the Company had 63,554,192 ordinary shares in issue. At 31 January 2026, the Company held 1,314,722 shares in treasury (2025: 8,640,808) and had 62,239,470 (2025: 64,272,192) shares outstanding, all of which have equal voting rights.

 

31 January 2026

31 January 2025

Shares held in treasury

1,314,722

8,640,808

Shares not held in treasury

62,239,470

64,272,192

Total

63,554,192

72,913,000

15 NET ASSET VALUE PER SHARE

The net asset value per share is calculated on equity attributable to equity holders of £1,272.6m (2025: £1,332.4m) and on 62,239,470 (2025: 64,272,192) ordinary shares in issue at the year end. There were no potentially dilutive shares, such as options or warrants, at either year end. Calculated on both the basic and diluted basis the net asset value per share was 2,044.6p (2025: 2,072.9p).

16 CAPITAL COMMITMENTS AND CONTINGENCIES

The Company and its subsidiaries had uncalled commitments in relation to the following Portfolio investments:

 

31 January 2026
£'000

31 January 2025
£'000

ICG LP Secondaries Fund II (Feeder) SCSp

65,758

ICG LP Secondaries Fund I LP

28,378

41,146

ICG Strategic Equity V

26,866

36,868

ICG Europe IX

21,447

ICG Europe Mid-Market Fund II1

17,543

19,245

ICG Augusta Partners Co-Investor

15,822

17,775

ICG Strategic Secondaries Fund II

15,340

16,938

ICG Ludgate Hill (Feeder B) SCSp1

14,081

13,591

ICG Europe VIII1

11,224

14,339

ICG Strategic Equity Fund III

10,166

11,201

ICG Europe VII1

5,907

6,082

ICG Strategic Equity IV

5,618

7,055

ICG Ludgate Hill (Feeder) IIIA Porsche SCSp

5,154

5,691

ICG Europe Mid-Market Fund1

4,966

5,524

ICG Ludgate Hill (Feeder) II Boston SCSp

4,883

5,392

ICG Ludgate Hill (Feeder) Domino SCSp

3,952

ICG Europe VI1

4,157

4,013

ICG Asia Pacific Fund III

2,242

2,523

ICG Midsummer

1,862

ICG North American Private Debt Fund II

1,804

2,097

ICG Colombe Co-investment1

1,876

1,811

Commitments of less than £1,000,000 at 31 January 2026

6,263

15,347

Total ICG

275,308

226,638

Graphite Capital Partners VIII2

4,124

4,124

Graphite Capital Partners IX

942

2,281

Graphite Capital Partners VII2

456

456

Total Graphite funds

5,522

6,861

1Includes interest acquired through a secondary fund purchase.

2.Includes the associated Top Up funds.

 

31 January 2026
£'000

31 January 2025
£'000

Advent International GPE XI-D Scsp

17,324

Green Equity Investors (Lux) X, S.C.Sp.

14,613

Thomas H Lee Equity Fund X

14,613

Hg Saturn 4 B L.P

14,576

Leeds VIII-A

12,886

16,135

PAI VIII

12,430

12,356

Integrum II

11,735

GHO Capital IV EUR LP

11,264

New Mountain Strategic Equity Fund II, L.P.

10,960

Bowmark VII

10,890

15,000

Thoma Bravo XVI-A

9,926

12,101

Cinven VIII

9,550

11,748

New Mountain VII

9,436

14,299

CVC IX A

9,240

10,546

Hg Genesis 11 B L.P

8,662

Investindustrial VIII

8,261

12,009

Bain VI

7,504

9,939

CDR XII

7,343

8,908

Hellman Friedman XI (Parallel)

7,306

8,067

Advent International X-A

6,517

8,039

Genstar Capital Partners XI (EU)

6,302

7,455

Apax XI EUR

6,248

6,860

Bregal Unternehmerkapital IV-A

6,247

7,762

The Resolute Fund VI

5,646

8,577

Permira VIII

5,409

7,618

Green Equity Investors Side IX

5,000

7,618

Investindustrial VII

4,143

4,895

Bowmark VI

3,975

3,357

Oak Hill VI (Offshore)

3,884

5,034

American Securities IX

3,653

4,034

Trident X Parallel Fund, L.P

3,653

TH Lee IX

3,271

3,998

Audax Private Equity VII-B

3,180

4,546

BC XI

3,166

3,710

Five Arrows III

3,151

1,823

CVC VII

3,140

2,944

Ivanti

2,698

2,979

Valeas Capital Partners I A

2,526

2,973

Charlesbank X

2,406

1,685

Hg Genesis X

2,324

3,326

Audiotonix

2,243

2,243

BSI Software

2,016

1,265

Commitments of less than £2,000,000 at 31 January 2026

55,192

85,838

Total third party

354,509

319,687

Total commitments

635,339

553,186

The Company and its subsidiaries had no other unfunded commitments to investment funds. Commitments made by the Company and its subsidiaries are irrevocable.

As at 31 January 2026, the Company (excluding its subsidiaries) had uncalled commitments in relation to the above Portfolio of £174.4m (2025: £114.3m). The Company did not have any contingent liabilities at 31 January 2026 (2025: none).

The Company’s subsidiaries, which are not consolidated, had the balance of uncalled commitments in relation to the above Portfolio of £460.9m (2025: £438.9m). The Company is responsible for financing its pro-rata share of those uncalled commitments (see Note 9).

17 FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

The Company is an investment company as defined by Section 833 of the Companies Act 2006 and conducts its affairs so as to qualify as an investment trust under the provisions of Section 1158 of the Corporation Tax Act 2010 (‘Section 1158’). The Company’s objective is to provide long-term growth by investing in private companies managed by leading private equity managers.

Investments in funds have anticipated lives of approximately 10 years. Direct Investments are made with an anticipated holding period of between three and five years.

Financial risk management

The Company’s activities expose it to a variety of financial risks: market risk (comprising currency risk, interest rate risk and price risk), investment risk, credit risk and liquidity risk. The Company’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Company’s financial performance. The Board has overall responsibility for managing the risks and the framework for monitoring and co-ordinating these risks. The Audit Committee regularly reviews, identifies and evaluates the risks taken by the Company to allow them to be appropriately managed. All of the Company’s management functions are delegated to the Manager which has its own internal control and risk monitoring arrangements. The Committee makes a regular assessment of these arrangements, with reference to the Company’s risk matrix. The Company’s financial risk management objectives and processes used to manage these risks have not changed from the previous period and the policies are set out below:

Market risk

(i) Currency risk

The Company’s investments are principally in continental Europe, the US and the UK, and are primarily denominated in euro, US dollars and sterling. There are also smaller amounts in other European currencies. The Company’s investments in controlled structured entities are reported in sterling. The Company is exposed to currency risk in that movements in the value of sterling against these foreign currencies will affect the net asset value and the cash required to fund undrawn commitments. The Board regularly reviews the level of foreign currency denominated assets and outstanding commitments in the context of current market conditions and may decide to buy or sell currency or put in place currency hedging arrangements. No hedging arrangements were in place during the financial year.

The composition of the net assets of the Company by reporting currency at the year end is set out below:

 

Sterling

Euro

USD

Other

Total

31 January 2026

£’000

£’000

£’000

£’000

£’000

Investments

1,026,902

85,458

196,546

(6)

1,308,900

Cash and cash equivalents and other net current assets/(liabilities)

(44,933)

6,233

2,369

3

(36,328)

 

981,969

91,691

198,915

(3)

1,272,572

 

 

 

 

 

 

 

Sterling

Euro

USD

Other

Total

31 January 2025

£’000

£’000

£’000

£’000

£’000

Investments

1,201,166

81,755

186,623

5

1,469,549

Cash and cash equivalents and other net current assets/(liabilities)

(139,168)

1,385

618

8

(137,157)

 

1,061,998

83,140

187,241

13

1,332,392

On a look-through basis to the currency of the portfolio company, the effect of a 25% increase or decrease in the sterling value of the euro would be a fall of £117.4m and a rise of £114.9m in the value of shareholders’ equity and on profit after tax at 31 January 2026 respectively (2025: a fall of £71.3m and a rise of £65.1m based on a 25% increase or decrease). The effect of a 25% increase or decrease in the sterling value of the US dollar would be a fall of £181.5m and a rise of £178.4m in the value of shareholders’ equity and on profit after tax at 31 January 2026 respectively (2025: a fall of £158m and a rise of £152.1m based on a 25% movement). The percentages applied are based on market volatility in exchange rates observed in prior periods.

(ii) Interest rate risk

The Company’s assets primarily comprise non-interest bearing investments in funds and non-interest bearing investments in portfolio companies. The fair values of these investments are not significantly directly affected by changes in interest rates. The Company’s net debt balance is exposed to interest rate risk; the financial impact of this risk is currently immaterial.

The Company is indirectly exposed to interest rate risk through the impact of interest rates on the performance of investments in funds and portfolio companies as a result of interest rate changes impacting the underlying manager valuation. This performance impact as a result of interest rate risk is recognised through the valuation of those investments, which will be affected by the impact of any change in interest rates on the financial performance of the underlying portfolio companies and also on any valuation of those investments for sale. The Company is not able to quantify how a change in interest rates would impact valuations.

(iii) Price risk

The risk that the value of a financial instrument will change as a result of changes to market prices is one that is fundamental to the Company’s objective, which is to provide long-term capital growth through investment in unquoted companies. The investment Portfolio is continually monitored to ensure an appropriate balance of risk and reward in order to achieve the Company’s objective.

The Company is exposed to the risk of change in value of its private equity investments. For all investments the market variable is deemed to be the price itself. The table below shows the impact of a 30% increase or decrease in the valuation of the investment Portfolio. The percentages applied are reasonable based on the Manager’s view of the potential for volatility in the Portfolio valuations under stressed conditions.

 

31 January 2026

31 January 2025

 

Increase in variable

Decrease in variable

Increase in variable

Decrease in variable

 

£’000

£’000

£’000

£’000

30% (2025: 30%) movement in the price of investments

 

 

 

 

Impact on profit after tax

372,686

(382,564)

423,339

(370,568)

A reasonably possible percentage change in relation to the earnings estimates or Enterprise Value/EBITDA multiples used by the underlying managers to value the private equity fund investments and co-investments may result in a significant change in fair value of unquoted investments

Investment and credit risk

(i) Investment risk

Investment risk is the risk that the financial performance of the companies in which the Company invests either improves or deteriorates, thereby affecting the value of that investment. Investments in unquoted companies whether indirectly or directly are, by their nature, subject to potential investment losses. The investment Portfolio is highly diversified in order to mitigate this risk.

(ii) Credit risk

The Company’s exposure to credit risk arises principally from its investment in cash deposits. The Company aims to invest the majority of its liquid portfolio in assets which have low credit risk. The Company’s policy is to limit exposure to any one investment to 15% of gross assets. This is regularly monitored by the Manager as a part of its cash management process.

Additionally, the Company is exposed to credit risk through its investments in unquoted companies and the company’s subsidiaries (refer to Note 10).

Cash is held on deposit with Royal Bank of Scotland (‘RBS’) and totalled £33.8m (2025: £3.9m). RBS currently has a credit rating of A1 from Moody’s. This represented the maximum exposure to credit risk at the balance sheet date. No collateral is held by the Company in respect of these amounts. None of the Company’s cash deposits or money market fund balances were past due or impaired at 31 January 2026 (2025: nil) and as a result of this, no ECL provision has been recorded.

Liquidity risk

The Company makes commitments to private equity funds in advance of that capital being invested, typically in illiquid, unquoted companies. These commitments are in excess of the Company’s total liquidity, therefore resulting in an overcommitment. When determining the appropriate level of overcommitment, the Board considers the rate at which commitments might be drawn down, typically over four to six years, versus the rate at which existing investments are sold and cash realised. The Company has an established liquidity management policy, which involves active monitoring and assessment of the Company’s liquidity position and its overcommitment risk. This is regularly reviewed by the Board and incorporated into the Board’s assessment of the viability of the Company.This process incorporates balance sheet and cash flow projections, including scenarios with varying levels of Portfolio gains and losses, fund drawdowns and realisations, availability of the credit facility, exchange rates and possible remedial action that the Company could undertake if required in the event of significant Portfolio declines.

At the year end, the Company had cash and cash equivalents totalling €33.8m and had access to committed bank facilities of £260m maturing in May 2029, which is a multi-currency revolving credit facility provided by SMBC and Lloyds. The key terms of the facility are:

  • Upfront cost: 120bps.

  • Non-utilisation fees: 115bps per annum.

  • Margin on drawn amounts: 300bps per annum.

As at 31 January 2026 the Company’s total financial liabilities amounted to £71.7m (2025: £143.1m) of payables which were due in less than one year, which includes accrued balances payable in respect of the credit facility above.

Movement in financial liabilities arising from financing activities

The following table sets out the movements in total liabilities held at amortised cost arising from financing activities undertaken during the year.

 

31 January 2026

31 January 2025

 

£’000

£’000

At 1 February

134,775

22,062

Proceeds from borrowings

126,608

139,762

Repayment of long term borrowings

(196,875)

(27,831)

Foreign exchange and other movements

2,061

782

At 31 January

66,569

134,775

 

 

 

Capital risk management

The Company’s capital is represented by its net assets, which are managed to achieve the Company’s investment objective. As at the year end, the Company had net debt of £32.7m (2025: £128.0m).

The Board can manage the capital structure directly since it has taken the powers, which it is seeking to renew, to issue and buy back shares and it also determines dividend payments. The Company complied with its externally imposed capital requirements with respect to the obligation and ability to pay dividends by Section 1159 of the Corporation Tax Act 2010 and by the Companies Act 2006, respectively. Total equity at 31 January 2026, the composition of which is shown on the balance sheet, was £1,272.6m (2025: £1,332.4m).

Fair values estimation

IFRS 13 requires disclosure of fair value measurements of financial instruments categorised according to the following fair value measurement hierarchy:

  • Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

  • Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 2).

  • Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

The valuation techniques applied to level 3 assets are described in Note 1(c) of the financial statements.
No investments were categorised as level 1 or level 2.

The Company’s policy is to recognise transfers into and transfers out of fair value hierarchy levels at the end of the reporting year when they are deemed to occur.

The sensitivity of the Company’s investments to a change in value is discussed on page 49.
The following table presents the assets that are measured at fair value at 31 January 2026 and 31 January 2025:

31 January 2026



 

 

 

 

Level 1

Level 2

Level 3

Total

£’000

£’000

£’000

£’000

Investments held at fair value

 

 

 

 

Unquoted investments – indirect

148,108

148,108

Unquoted investments – direct

166,831

166,831

Quoted investments – direct

Subsidiary undertakings

993,961

993,961

Total investments held at fair value

1,308,900

1,308,900


31 December 2025



 

 

 

 

Level 1

Level 2

Level 3

Total

£’000

£’000

£’000

£’000

Investments held at fair value

 

 

 

 

Unquoted investments – indirect

150,987

150,987

Unquoted investments – direct

154,242

154,242

Quoted investments – direct

Subsidiary undertakings

1,164,320

1,164,320

Total investments held at fair value

1,469,549

1,469,549

All investments are valued at fair value in accordance with IFRS 13. The Company has no quoted investments as at 31 January 2026 (2025: nil); quoted investments held by subsidiary undertakings are reported within Level 3.

Investments in Level 3 securities are in respect of private equity fund investments and co-investments. These are held at fair value and are calculated using valuations provided by the underlying manager of the investment, with adjustments made to the statements to take account of cash flow events occurring after the date of the manager’s valuation, such as realisations or liquidity adjustments.

The following tables present the changes in Level 3 instruments for the year to 31 January 2026 and 31 January 2025.

31 January 2026

Unquoted investments (indirect) at fair value through profit or loss
£’000

Unquoted investments (direct) at fair value through profit or loss
£’000

Subsidiary undertakings
£’000

Total
£’000

Opening balances

153,045

152,184

1,164,320

1,469,549

Additions

21,171

29,435

154,590

205,196

Disposals

(33,486)

(26,681)

(320,138)

(380,305)

Gains and losses recognised in profit or loss

16,190

3,081

(4,811)

14,460

Closing balance

156,920

158,019

993,961

1,308,900


31 January 2025

Unquoted investments (indirect) at fair value through profit or loss
£’000

Unquoted investments (direct) at fair value through profit or loss
£’000

Subsidiary undertakings
£’000

Total
£’000

Opening balances

136,473

123,823

1,036,086

1,296,382

Additions

18,124

16,020

151,292

185,436

Disposals

(16,076)

(4,138)

(125,769)

(145,983)

Gains and losses recognised in profit or loss

14,524

16,479

102,711

133,714

Closing balance

153,045

152,184

1,164,320

1,469,549

The additions figure includes amounts of £11.1m (2025: £8.9m) from the parent to subsidiary which relate to incentive payments that are included in the ‘Cash flow to subsidiaries’ investments line in the Cash Flow Statement. The gains and losses recognised in profit or loss in the note do not align directly with the Income Statement due to difference in classification and disclosure requirements.

18 RELATED PARTY TRANSACTIONS

Significant transactions between the Company and its subsidiaries are shown below:

Subsidiary

Nature of transaction

Year ended
31 January
2026
£’000

Year ended
31 January
2025
£’000

ICG Enterprise Trust Limited Partnership

Increase in amounts owed to subsidiaries

492

 

Decrease in amounts owed to subsidiaries

(8,689)

 

Income allocated

ICG Enterprise Trust (2) Limited Partnership

Increase in amounts owed to subsidiaries

4,714

 

Decrease in amounts owed to subsidiaries

(2,956)

 

Income allocated

52

(169)

ICG Enterprise Trust Co-Investment LP

Increase in amounts owed by subsidiaries

33,229

 

Decrease in amounts owed to subsidiaries

(59,839)

 

Income allocated

2,444

2,127

ICG Enterprise Holdings LP

Increase in amounts owed by subsidiaries

 

Decrease in amounts owed to subsidiaries

 

Income allocated

3,410

4,224

ICG Morse Partnership LP

Increase in amounts owed by subsidiaries

 

Decrease in amounts owed to subsidiaries

 

Income allocated

ICG Lewis Partnership LP

Increase in amounts owed by subsidiaries

446

687

 

Decrease in amounts owed to subsidiaries

 

Income allocated

ICG Lewis (Delaware) LLC

Increase in amounts owed by subsidiaries

 

Decrease in amounts owed to subsidiaries

 

Income allocated

ICG Enterprise Trust Limited Partnership transferred its remaining assets to ICG Enterprise Trust PLC during the year ended 31 January 2025. The Partnership was dissolved on 31 July 2025 and ceased to be a subsidiary.

For the purpose of IAS 24 Related Party Disclosures, key management personnel comprised the Board of Directors.

Remuneration in the year (audited)

Fees

Expenses

Total

Name

2026
£’000

2025
£’000

2026
£’000

2025
£’000

2026
£’000

2025
£’000

Jane Tufnell

76

74

76

74

Alastair Bruce

62

60

62

60

David Warnock

61

59

61

59

Gerhard Fusenig1

50

48

2

3

52

51

Adiba Ighodaro

50

48

50

48

Janine Nicholls

50

48

50

48

Total

349

337

2

3

351

340

1 Gerhard Fusenig is resident in Switzerland and the Company has agreed to pay for his costs of travel to London (including appropriate accommodation) to attend meetings of the Board.

Amounts owed by/to subsidiaries represent the Company’s loan account balances with those entities, to which the Company’s share of drawdowns and distributions in respect of those entities are credited and debited respectively.

 

Amount owed by subsidiaries

Amount owed to subsidiaries

Subsidiary

31 January 2026
£’000

31 January 2025
£’000

31 January 2026
£’000

31 January 2025
£’000

ICG Enterprise Trust Limited Partnership

(492)

ICG Enterprise Trust (2) Limited Partnership

36,085

31,372

ICG Enterprise Trust Co-Investment LP

213,716

273,555

ICG Enterprise Holdings LP

ICG Morse Partnership LP

ICG Lewis Partnership LP

9,015

8,569

ICG Lewis (Delaware) LLC

The Company and its subsidiaries’ total shares in funds and co-investments managed by the Company’s Manager are:

 

Year ended 31 January 2026

Year ended 31 January 2025

Fund/Co-investment

Remaining
commitment
£’000

Fair value investment
£’000

Remaining
commitment
£’000

Fair value investment
£’000

ICG Strategic Equity IV

5,618

34,146

7,055

32,851

ICG Europe VIII

11,224

32,346

14,339

23,640

ICG Vanadium Co-Investment

255

23,497

246

16,180

ICG Strategic Equity Fund III

10,166

21,740

10,727

31,043

ICG LP Secondaries Fund I LP

28,378

21,061

41,146

12,175

ICG Ludgate Hill (Feeder B) SCSp

14,081

18,409

13,591

23,814

ICG Strategic Equity V

26,866

17,949

36,868

7,101

ICG Ludgate Hill (Feeder) Domino SCSp

3,952

17,364

ICG Augusta Partners Co-Investor

15,822

16,189

17,775

20,469

ICG Midsummer

1,862

14,965

ICG Ludgate Hill (Feeder) III A Porsche SCSp

5,154

14,552

5,691

17,995

ICG Colombe Co-investment

1,876

14,404

1,810

13,795

ICG Cheetah Co-Investment

636

14,379

635

11,123

ICG Ludgate Hill (Feeder) II Boston SCSp

4,883

13,878

5,392

16,030

CX VIII Co-Investment

173

13,062

167

9,076

ICG Match Co-Investment

119

12,904

132

15,253

ICG Europe VII

5,907

12,879

6,082

30,721

ICG MXV Co-Investment

245

12,690

8,361

32,728

ICG Europe Mid-Market Fund

4,966

12,354

5,524

13,494

ICG Newton Co-Investment

393

10,167

393

17,808

ICG Dallas Co-Investment

797

8,600

1,240

8,172

ICG Asia Pacific Fund III

2,242

6,985

2,523

8,706

ICG Sunrise Co-Investment

77

6,399

75

5,840

ICG Recovery Fund 2008 B1

728

5,758

846

4,954

ICG Crown Co-Investment

58

4,910

96

5,492

ICG Europe Mid-Market II

17,543

4,163

19,245

1,534

ICG Strategic Secondaries Fund II

15,340

4,016

16,938

4,853

ICG Holiday Co-Investor I

259

2,944

286

3,748

ICG Holiday Co-Investor II

180

2,178

199

2,775

ICG North American Private Debt Fund II

1,804

1,937

2,097

3,061

ICG Europe VI

4,157

1,130

4,013

2,814

ICG Europe IX

21,447

234

ICG Europe V

561

127

545

757

ICG Diocle Co-Investment

150

65

145

81

ICG Velocity Partners Co-Investor

588

16

650

18

ICG European Fund 2006 B1

497

5

480

15

ICG Cross Border

165

182

273

ICG LP Secondaries Fund II (Feeder) SCSp

65,758

ICG Progress Co-Investment

381

421

17,265

ICG Trio Co-Investment

36

ICG Topvita Co-Investment

687

Total

275,308

398,401

226,638

415,652

At the balance sheet date the Company has fully funded its share of capital calls due to ICG-managed funds in which it is invested.

19 Post Balance Sheet Events

There have been no material events since the balance sheet date.

GLOSSARY

Term

Short form

Definition

Alternative Performance Measures

APMs

Alternative Performance Measures (‘APMs’) are a term defined by the European Securities and Markets Authority as ‘financial measures of historical or future performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework’.
APMs are used in this report if considered by the Board and the Manager to be the most relevant basis for shareholders in assessing the overall performance of the Company and for comparing the performance of the Company to its peers, taking into account industry practice.
Definitions and reconciliations to IFRS measures are provided in the main body of the report or in this Glossary, where appropriate.

Buyback impact on NAV per Share























 

Buyback impact on NAV per Share is calculated by comparing the NAV per Share with an adjusted NAV per Share as follows:

 

Year ended
31 January 2026

Since inception (Oct. 22)

 

Opening number of shares

64,278,192

68,517,055

A

Number of shares bought back in period

2,038,722

6,277,585

 

Closing number of shares

62,239,470

62,239,470

B

31 January 2026 NAV

£1,273m

£1,273m

C

Add back cash invested in buybacks

£28m

£79m

 

31 January 2026 NAV
+ cash invested in buybacks

£1,300m

£1,351m

D

31 January 2026 NAV per Share

2,044.6 p

2,044.6 p

E (C/B)

Pro forma NAV per share excluding buybacks

2,023.1p

1,972.0p

F (D/A)

Impact of buybacks

21.5p

72.6p

G (E-F)

NAV per Share accretion
from buybacks

1.1%

3.7%

G/F

Note: scenario excluding buyback does not include any cash impact of dividends that would have been paid to holders of those shares had the buyback not been undertaken.

Carried Interest

 

Carried Interest is equivalent to a performance fee. This represents a share of the profits that will accrue to the underlying private equity managers, after achievement of an agreed Preferred Return.

Cash drag

 

Cash drag is the negative impact on performance arising as a result of the allocation of a portion of the entity’s assets to cash.

Co-investment

 

Co-investment is a Direct Investment in a company alongside a private equity fund.

Co-investment Incentive Scheme Accrual

 

Co-investment Incentive Scheme Accrual represents the estimated value of interests in the Co-investment Incentive Scheme operated by the subsidiary partnerships of the Company.

Commitment

 

Commitment represents the amount of capital that each investor agrees to contribute to a fund or a specific investment.

Compound Annual Growth Rate

CAGR

The rate of return that would be required for an investment to grow from its beginning balance to its ending balance, assuming the profits were reinvested at the end of each period of the investment’s life span.

Deployment

 

See ‘Total new investment’

Direct Investment

 

An investment in a portfolio company held directly, not through a private equity fund. Direct Investments are typically co-investments with a private equity fund.

Discount

 

Discount arises when the Company’s shares trade at a price below the Company’s NAV per Share. In this circumstance, the price that an investor pays or receives for a share would be less than the value attributable to it by reference to the underlying assets. The Discount is the difference between the share price and the NAV, expressed as a percentage of the NAV. For example, if the NAV was 100p and the share price was 90p, the Discount would be 10%.

Drawdowns

 

Drawdowns are amounts invested by the Company when called by underlying managers in respect of an existing Commitment.

EBITDA

 

Stands for earnings before interest, tax, depreciation and amortisation, which is a widely used profitability measure in the private equity industry.

Enlarged Perimeter

 

The aggregate value of the Top 30 Companies and as many of the managers from within the Top 30 funds as practicable (70% of Portfolio Value at 31 January 2026).

Enterprise Value

EV

Enterprise Value is the aggregate value of a company’s entire issued share capital and Net Debt.

Exclusion List

 

The Exclusion List defines the business activities which are excluded from investment.

FTSE All-Share Index Total Return

 

The change in the level of the FTSE All-Share Index, assuming that dividends are re-invested on the day that they are paid.

Full Exits

 

Full Exits are exit events (e.g., trade sale, sale by public offering, or sale to a financial buyer) following which the residual exposure to an underlying company is zero or immaterial; this does not include Fund Disposals. See ‘Fund Disposals’.

Fund Disposals

 

Fund Disposals are where the Company receives sales proceeds from the full or partial sale of a fund position within the secondary market.

General Partner

GP

The General Partner is the entity managing a private equity fund. This is commonly referred to as the manager.

Hedging

 

Hedging is an investment technique designed to offset a potential loss on one investment by purchasing a second investment that is expected to perform in the opposite way.

Initial Public Offering

IPO

An Initial Public Offering is an offering by a company of its share capital to the public with a view to seeking an admission of its shares to a recognised stock exchange.

Internal Rate of Return

IRR

Internal Rate of Return is a measure of the rate of return received by an investor in a fund. It is calculated from cash drawn from and returned to the investor, together with the residual value of the investment.

Investment Period

 

Investment Period is the period in which funds are able to make new investments under the terms of their fund agreements, typically up to five years after the initial Commitment.

Last Twelve Months

LTM

Last Twelve Months refers to the timeframe of the immediately preceding 12 months in reference to financial metrics used to evaluate the Company’s performance.

Limited Partner



LP

The Limited Partner is an institution or individual who commits capital to a private equity fund established as a Limited Partnership. These funds are generally protected from legal actions and any losses beyond the original investment.

Limited Partnership





 

A Limited Partnership includes one or more General Partners, who have responsibility for managing the business of the partnership and have unlimited liability, and one or more Limited Partners, who do not participate in the operation of the partnership and whose liability is ordinarily capped at their capital and loan contribution to the partnership. In typical fund structures, the General Partner receives a priority share ahead of distributions to Limited Partners.



Net Asset Value per Share

NAV per Share

Net Asset Value per Share is the value of the Company’s net assets attributable to one Ordinary share. It is calculated by dividing ‘shareholders’ funds’ by the total number of ordinary shares in issue, excluding treasury shares. Shareholders’ funds are calculated by deducting current and long-term liabilities, and any provision for liabilities and charges, from the Company’s total assets.

Net Debt

 

Net Debt is calculated as the total short-term and long-term debt in a business, less cash and cash equivalents.

Ongoing charges

 

Ongoing Charges are calculated capturing management fees and expenses, excluding finance costs, incurred at the Company level only. The calculation does not include the expenses and management fees incurred by any underlying funds.

 

 

31 January 2026

Total per income statement
£'000

Amount excluded from Ongoing Charges
£'000

Included Ongoing Charges
£000

 

 

Management fees

16,063

 

16,063

 

 

General expenses

2,273

(473)

1,800

 

 

Finance costs

9,775

(9,775)

 

 

Total

28,111

(10,248)

17,863

 

 

Total Ongoing Charges

17,863

 

 

Average NAV

1,285,750

 

 

Ongoing Charges as % of NAV

1.39%

 

 

 

 

 

 

 

 

31 January 2025

Total per income statement
£'000

Amount excluded from Ongoing Charges
£'000

Included Ongoing Charges
£000

 

 

Management fees

16,175

16,175

 

 

General expenses

1,500

165

1,665

 

 

Finance costs

9,354

(9,354)

 

 

Total

27,029

(9,189)

17,840

 

 

Total Ongoing Charges

17,840

 

 

Average NAV

1,294,186

 

 

Ongoing Charges as % of NAV

1.38%

 

 

Included within General expenses above are £0.5m (2025: £0.2m (credit)) of other expenses which are non-recurring and are excluded from the Ongoing Charges.

Other Net Liabilities

 

Other Net Liabilities at the aggregated Company level represent net other liabilities per the Company’s balance sheet. Net other liabilities per the balance sheet of the subsidiaries include amounts payable under the Co-investment Incentive Scheme Accrual.

Overcommitment

 

Overcommitment refers to where private equity fund investors make Commitments exceeding the amount of liquidity immediately available for investment. When determining the appropriate level of Overcommitment, careful consideration needs to be given to the rate at which Commitments might be drawn down, and the rate at which realisations will generate cash from the existing Portfolio to fund new investment.


Portfolio

 

Portfolio represents the aggregate of the investment Portfolios of the Company and of its subsidiary Limited Partnerships. This APM is consistent with the commentary in previous annual and interim reports. The Board and the Manager consider that disclosing our Portfolio assists shareholders in understanding the value and performance of the underlying investments selected by the Manager. It is shown before the Co-investment Incentive Scheme Accrual to avoid being distorted by certain funds and Direct Investments on which ICG Enterprise Trust Plc does not incur these costs (for example, on funds managed by ICG plc). Portfolio is related to the NAV, which is the value attributed to our shareholders, and which also incorporates the Co-investment Incentive Scheme Accrual as well as the value of cash and debt retained on our balance sheet.

The value of the Portfolio at 31 January 2026 is £1,352.9m (31 January 2025: £1,523.1m).

 

 

31 January 2026 £m

IFRS Balance sheet fair value

Net assets of subsidiary limited partnerships

Co-investment Incentive Scheme Accrual

Total Company and subsidiary Limited Partnership

 

 

Investments1

1,308.9

(0.4)

44.4

1,352.9

 

 

Cash

33.8

33.8

 

 

Other Net Liabilities

(70.1)

0.4

(44.4)

(114.1)

 

 

Net assets

1,272.6

1,272.6

 

 

 

 

 

 

 

 

 

31 January 2025 £m

IFRS Balance sheet fair value

Net assets of subsidiary limited partnerships

Co-investment Incentive Scheme Accrual

Total Company and subsidiary Limited Partnership

 

 

Investments1

1,469.5

(0.3)

53.9

1,523.1

 

 

Cash

3.9

3.9

 

 

Other Net Liabilities

(141.0)

0.3

(53.9)

(194.6)

 

 

Net assets

1,332.4

1,332.4

 

 

1Investments as reported on the IFRS balance sheet at fair value comprise the total of assets held by the Company and the net asset value of the Company’s investments in the subsidiary Limited Partnerships.

Portfolio Return on a Local Currency Basis

 

Portfolio Return on a Local Currency Basis represents the change in the valuation of the Company’s Portfolio before the impact of currency movements and Co-investment Incentive Scheme Accrual. The Portfolio return of 4.8% is calculated as follows:

 

 

£m

 

31 January 2026

31 January 2025

 

 

Income, gains and losses on Investments

 

126.3

142.0

 

 

Foreign exchange gains and losses included in gains and losses on investments

 

(55.1)

5.4

 

 

Incentive accrual valuation movement

 

1.7

(9.3)

 

 

Total gains on Portfolio investments excluding impact of foreign exchange

 

72.9

138.1

 

 

Opening Portfolio valuation

 

1,523.1

1,349.0

 

 

Portfolio Return on a Local Currency Basis

 

4.8%

10.2%

 

 

 

 

 

 

 


Term

Short form

Definition

Portfolio Company

 

Portfolio Company refers to an individual company in an investment portfolio.

Primary

 

A Primary Investment is a Commitment to a private equity fund.

Preferred Return

 

Preferred Return is the preferential rate of return on an individual investment or a portfolio of investments, which is typically 8% per annum.

Premium

 

Premium occurs when the share price is higher than the NAV and investors would therefore be paying more than the value attributable to the shares by reference to the underlying assets.

Quoted Company

 

A Quoted Company is any company whose shares are listed or traded on a recognised stock exchange.

Realisation Proceeds

 

Realisation Proceeds are amounts received in respect of underlying realisation activity from the Portfolio and exclude any inflows from the sale of fund positions via the secondary market.

Realisations - Multiple to Cost

 

Realisations - Multiple to Cost is the average return from Full Exits from the Portfolio in the period on a primary investment basis, weighted by cost.

 

 

£m

 

31 January 2026

31 January 2025

 

 

Realisation Proceeds from Full Exits in the year-to-date

 

195.8

73.7

 

 

Cost

 

80.2

35.9

 

 

Average multiple of cost

 

3.0x

2.9x

Realisations – Uplift To Carrying Value

 

Realisations – Uplift To Carrying Value is the aggregate uplift on Full exits from the Portfolio in the period comparing realisation proceeds to the most recent valuation prior to the announcements of the disposal. This measure excludes publicly listed companies that were exited via sell downs of their shares.

 

 

£m

 

31 January 2026

31 January 2025

 

 

Realisation Proceeds from Full Exits in the year-to-date

 

195.8

73.7

 

 

Prior Carrying Value (most recent valuation prior to the announcement of the disposal)

 

176.1

62.0

 

 

Realisations – Uplift To Carrying Value

 

11.2%

19.0%

Secondary Investments

 

Secondary Investments occur when existing private equity fund interests and Commitments are purchased from an investor seeking liquidity.

Share buybacks

 

Share buybacks, or stock repurchases, occur when a company uses its own funds to buy its outstanding shares in the open market, thereby reducing the number of shares in circulation. As a result of buybacks, existing shareholders own a greater percentage of the company’s assets and profits. If share buybacks are executed at a discount to NAV, the buyback will increase the NAV per Share of the remaining shares outstanding.

Share Price Total Return

 

Share Price Total Return is the change in the Company’s share price, assuming that dividends are re-invested on the day that they are paid.

Total New Investment

 

Total New Investment is the total of direct Co-investment and fund investment Drawdowns in respect of the Portfolio. In accordance with IFRS 10, the Company’s subsidiaries are deemed to be investment entities and are included in subsidiary investments within the financial statements.



Movements in the cash flow statement within the financial statements reconcile to the movement in the Portfolio as follows:

 

 

£m

 

31 January 2026

31 January 2025

 

 

Purchase of Portfolio investments per cash flow statement

 

50.6

34.1

 

 

Purchase of Portfolio investments within subsidiary investments

 

154.8

152.2

 

 

Return of invested cost/expenses

 

(11.1)

(4.9)

 

 

Total New Investment

 

194.2

181.4


Term

Short form

Definition

 

 

 

 

Total Proceeds

 

Total Proceeds are amounts received by the Company in respect of the Portfolio, which may be in the form of capital proceeds or income such as interest or dividends. In accordance with IFRS 10, the Company’s subsidiaries are deemed to be investment entities and are included in subsidiary investments within the financial statements.

 

 

£m

 

 

31 January 2026

31 January 2025

 

 

Sale of Portfolio investments per cash flow statement

 

 

60.1

20.0

 

 

Sale of Portfolio investments, interest received, and dividends received within subsidiary investments

 

 

320.1

125.8

 

 

Interest income per cash flow statement

 

 

0.7

0.5

 

 

Dividend income per cash flow statement

 

 

1.5

0.5

 

 

Other income per cash flow statement

 

 

0.3

0.1

 

 

Return of invested cost

 

 

3.6

4.6

 

 

Deal costs arising from Secondary Sales

 

 

(3.9)

(0.6)

 

 

Total Proceeds

 

 

382.3

150.8

 

 

Fund Disposals

 

 

(66.3)

 

 

Realisation Proceeds

 

 

316.0

150.8

Total Return

 

The change in the Company’s Net Asset Value per Share, assuming that dividends are re-invested at the end of the quarter in which the dividend was paid.

Undrawn Commitments

 

Undrawn Commitments are Commitments that have not yet been drawn down (please see ‘Drawdowns’).

Unquoted Company

 

An Unquoted Company is any company whose shares are not listed or traded on a recognised stock exchange.

Valuation Date

 

The date of the valuation report issued by the underlying manager.